TIDMDPLM
RNS Number : 6768H
Diploma PLC
19 November 2018
DIPLOMA PLC
12 CHARTERHOUSE SQUARE, LONDON EC1M 6AX
TELEPHONE: +44 (0)20 7549 5700
FACSIMILE: +44 (0)20 7549 5715
FOR IMMEDIATE RELEASE
19 November 2018
DIPLOMA PLC
PRELIMINARY ANNOUNCEMENT OF FINAL RESULTS
FOR THE YEARED 30 SEPTEMBER 2018
"Strong Results with Double-Digit Earnings Growth"
Audited Audited
2018 2017
GBPm GBPm
Revenue 485.1 451.9 +7%
Adjusted operating profit(1) 84.9 78.2 +9%
Adjusted operating margin(1) 17.5% 17.3% +20bps
Adjusted profit before
tax(1),(2) 84.8 77.5 +9%
Statutory operating profit 73.2 68.5 +7%
Statutory profit before
tax 72.7 66.8 +9%
Statutory profit for
the year 54.4 48.2 +13%
Free cash flow(3) 60.5 55.7 +9%
Pence Pence
Adjusted earnings per
share(1),(2) 56.4 49.8 +13%
Basic earnings per share 47.5 42.0 +13%
Total dividend per share 25.5 23.0 +11%
(1) Before acquisition related charges and Chief Executive
Officer transition costs
(2) Before fair value remeasurements
(3) Before cash payments on acquisitions and dividends
Financial Highlights
* Revenue and adjusted operating profit increased by 7%
and 9%, respectively.
* Underlying revenues increased by 7%; 3% increase in
revenues from businesses acquired (net of a small
disposal), offset by 3% currency headwind.
* Adjusted operating margins improved by 20bps to 17.5%,
reflecting benefit of operational leverage from
growth in revenues.
* Adjusted profit before tax increased by 9% to
GBP84.8m; adjusted EPS increased by 13% to 56.4p,
reflecting benefit from a reduction in US Federal
corporate income tax rate.
* Robust free cash flow of GBP60.5m, including GBP4.0m
realised on sale of business; strong balance sheet
with cash funds of GBP36.0m at end of September.
* Total dividend increased by 11% to 25.5p per share
reflecting strong financial position and confidence
in Group's prospects.
Operational Highlights
* In Life Sciences underlying revenues increased by 5%.
Healthcare businesses benefited from strong
consumable revenues and new premium Surgical and
Endoscopy products; Environmental businesses had a
mixed year, with stronger revenues in Germany offset
by reduced UK revenues.
* In Seals, underlying revenues increased by 10%.
Aftermarket and Industrial OEM businesses in North
America benefited from buoyant US industrial economy;
International Seals businesses reported solid growth
in second half of year led by a good performance in
Europe.
* In Controls, underlying revenues increased by 5%. The
Interconnect and Specialty Fasteners businesses
increased revenues helped by stronger industrial
markets and success in broadening their customer
base; weaker revenues in Fluid Controls were
principally due to the absence of a large one-off
project.
* Acquisition expenditure was GBP20.4m with GBP16.9m
invested in the acquisition of FS Cables, taking the
Group's expenditure on value-enhancing businesses
over the past five years to ca. GBP128m; the Group's
return on adjusted trading capital ("ROATCE") has
improved to 24.5%, comfortably exceeding our 20%
target.
Commenting on the results for the year, John Nicholas, Diploma's
Executive Chairman said:
"Diploma's trading performance in 2018 was, once again, very
strong. The Group delivered another year of double-digit growth
in adjusted earnings per share and generated free cash flow of
over GBP60m. The results demonstrate the resilience of the Group's
businesses and the consistent delivery against the Group's strategy
which has delivered compound double-digit growth in adjusted
earnings per share over the past 10 years.
Despite the global macro-economic uncertainty, the Board remains
confident that the Group will continue to make further progress
in the coming year from a combination of steady "GDP plus" underlying
growth and from the Group's proven and value-enhancing acquisition
programme."
There will be a presentation of the results to analysts and investors
at 9.00am this morning at Pewterers' Hall, Oat Lane, City of
London, EC2V 7DE. This presentation will be made available as
a webcast from 2.00pm GMT via www.diplomaplc.com/investors/financial-presentations/
For further information please contact:
Diploma PLC - +44 (0)20 7549 5700
John Nicholas, Executive Chairman
Nigel Lingwood, Group Finance Director
Tulchan Communications - +44 (0)20 7353 4200
David Allchurch
Martin Robinson
Notes:
* Diploma PLC uses alternative performance measures as
key financial indicators to assess the underlying
performance of the Group. These include adjusted
operating profit, adjusted profit before tax,
adjusted earnings per share, free cash flow and
ROATCE. All references in this Preliminary
Announcement ("Announcement") to "underlying"
revenues or operating profits refer to reported
results on a constant currency basis and before any
contribution from acquired or disposed businesses.
The narrative in this Announcement is based on these
alternative measures and an explanation is set out in
notes 2 and 3 to the consolidated financial
statements in this Announcement.
* Certain statements contained in this Announcement
constitute forward-looking statements. Such
forward-looking statements involve risks,
uncertainties and other factors which may cause the
actual results, performance or achievements of
Diploma PLC, or industry results, to be materially
different from any future results, performance or
achievements expressed or implied by such statements.
Such risks, uncertainties and other factors include,
among others, exchange rates, general economic
conditions and the business environment.
NOTE TO EDITORS:
Diploma PLC is an international group of businesses supplying
specialised technical products and services to the Life Sciences,
Seals and Controls industries.
Diploma's businesses are focussed on supplying essential products
and services which are funded by the customers' operating rather
than their capital budgets, providing recurring income and stable
revenue growth.
Our businesses then design their individual business models to
closely meet the requirements of their customers, offering a
blend of high quality customer service, deep technical support
and value adding activities. By supplying essential solutions,
not just products, we build strong long term relationships with
our customers and suppliers, which support attractive and sustainable
margins.
Finally, we encourage an entrepreneurial culture in our businesses
through our decentralised management structure. We want our managers
to feel that they have the freedom to run their own businesses,
while being able to draw on the support and resources of a larger
group. These essential values ensure that decisions are made
close to the customer and that the businesses are agile and responsive
to changes in the market and the competitive environment.
The Group employs ca. 1,800 employees and its principal operating
businesses are located in the UK, Northern Europe, North America
and Australia.
Over the last ten years, the Group has grown adjusted earnings
per share at an average of ca. 13% p.a. through a combination
of underlying growth and acquisitions. Diploma is a member of
the FTSE 250 with a market capitalisation of ca. GBP1.6bn.
Further information on Diploma PLC can be found at www.diplomaplc.com
LEI: 2138008OG17VYG8FGR19
PRELIMINARY ANNOUNCEMENT OF FINAL RESULTS
FOR YEARED 30 SEPTEMBER 2018
EXECUTIVE CHAIRMAN'S STATEMENT
Diploma's trading performance in 2018 was, once again, very
strong. The Group delivered another year of double-digit growth in
adjusted earnings per share and generated free cash flow of over
GBP60m. The results demonstrate the resilience of the Group's
businesses and the consistent delivery against the Group's strategy
that have allowed Diploma to build a long track record of strong
financial performance despite the vagaries of the macroeconomic
environment during any period.
During the year the Board appointed a new Chief Executive
Officer ("CEO") to succeed Bruce Thompson who retired from the
Board after leading the Group for over 20 years. However, in August
it was announced that Richard Ingram stepped down from his role as
CEO and that I had agreed to take over as interim Executive
Chairman until a new CEO is appointed. This process is underway and
the Board is confident that we will find the right CEO to lead the
Group to continued success. Over the course of this year, I have
been consistently impressed by the capability and commitment of the
Group's senior management team and I am grateful for their
continued support and hard work during this period. My particular
thanks are extended to our Group Finance Director, Nigel Lingwood,
for the strength and leadership he has demonstrated throughout the
year.
The Board has reviewed and reconfirmed its support for the
Group's existing strategy, that we believe continues to have
excellent potential to create shareholder value in the years ahead.
In addition to the underlying growth achieved this year, two
acquisitions were completed during the year and a further small
acquisition was also completed shortly after the year end.
Results
Group revenues increased in 2018 by 7% to GBP485.1m (2017:
GBP451.9m), despite a currency headwind of 3% from translating the
results of the overseas businesses, following a small appreciation
in UK sterling this year. After adjusting for the contribution from
acquisitions completed both this year and last year, net of a small
disposal this year and for these currency effects on translation,
Group revenues also increased by 7% on an underlying basis. The
Seals businesses delivered strong underlying revenue growth of 10%
and both the Life Sciences and Controls businesses reported a 5%
growth in underlying revenues.
Adjusted operating profit increased by 9% to GBP84.9m (2017:
GBP78.2m) reflecting the strong growth in revenues and a modest
increase of 20bps in adjusted operating margins to 17.5% (2017:
17.3%). Adjusted profit before tax also increased by 9% to GBP84.8m
(2017: GBP77.5m) and adjusted earnings per share ("EPS") increased
by 13% to 56.4p (2017: 49.8p), reflecting the benefit from the
reduction in the US Federal corporate income tax rate during the
year.
On a statutory basis, the Group's operating profit was 7% ahead
of last year at GBP73.2m (2017: GBP68.5m) after GBP9.6m (2017:
GBP9.7m) of acquisition related charges, largely comprising
amortisation of acquired intangible assets and one-off charges of
GBP2.1m with respect to the CEO change in the year. Statutory
profit before tax increased by 9% to GBP72.7m (2017: GBP66.8m) and
statutory EPS was 13% up on last year at 47.5p (2017: 42.0p).
The Group's free cash flow remained robust at GBP60.5m (2017:
GBP55.7m), which included GBP4.0m from the sale of a small non-core
US gasket business. The outflow of cash to support working capital
increased again this year by GBP5.1m (2017: GBP4.0m) reflecting the
much stronger trading environment across the Group. Capital
expenditure increased this year to GBP6.6m (2017: GBP3.3m) with
investment focused on new facilities and IT infrastructure and a
large investment by the Healthcare businesses in field equipment in
support of customer contracts.
As indicated in last year's Annual Report, the environment to
complete acquisitions continued to be challenging as vendors
postponed their exit plans in the face of the continuing favourable
macroeconomic conditions. The Group invested GBP20.4m (2017:
GBP20.1m) in acquisitions and there were tentative signs towards
the end of the year that this environment was easing. The pipeline
of acquisition opportunities remains healthy and we are confident
that good quality businesses in our acquisition pipeline will be
brought to market by their vendors.
The Group's balance sheet remains robust with cash funds at 30
September 2018 of GBP36.0m (2017: GBP22.3m), after investing
GBP20.4m in acquisitions and making distributions to shareholders
of GBP26.8m (2017: GBP23.5m). The Group also has unutilised
committed bank facilities of GBP30m with an accordion option to
extend these facilities up to GBP60m.
Dividends
The combination of strong results and free cash flow, supported
by a robust balance sheet has led the Board to recommend an
increase in the final dividend of 11% to 17.8p per share (2017:
16.0p). Subject to shareholder approval at the Annual General
Meeting ("AGM"), this dividend will be paid on 23 January 2019 to
shareholders on the register at 30 November 2018.
The total dividend per share for the year will be 25.5p (2017:
23.0p), which represents an 11% increase on 2017, with the level of
dividend cover remaining unchanged at 2.2 times on an adjusted EPS
basis.
Governance
During the year, we completed an external evaluation of the
Board. The results of the review were discussed by the Board and an
action plan to implement suggested improvements has been prepared.
The review included an in-depth analysis of the CEO recruitment
process with specific lessons to learn for the new search. The
Nomination and Remuneration Committees have been focused during the
latter part of the year on the leadership change and search for a
new CEO. The Audit Committee has overseen the transition of the
audit to the new auditor, PricewaterhouseCoopers LLP.
Employees
We continue to foster an entrepreneurial culture that encourages
our employees to take responsibility for their own businesses. I
would like to record my thanks to all our employees whose hard work
and commitment has again been a driving force behind the Group's
performance and the achievement of another year of strong financial
results.
Outlook
Diploma has a strong and resilient business model with a broad
geographic spread of businesses supported by a robust balance sheet
and consistently strong free cash flow. This model has delivered
another strong result this year with double-digit growth in
earnings per share, benefiting from favourable trading conditions
in most of its major markets.
Despite the global macro-economic uncertainty, the Board remains
confident that the Group will continue to make further progress in
the coming year from a combination of steady "GDP plus" underlying
growth and from the Group's proven acquisition programme.
OUR YEAR IN REVIEW
Financial performance
In 2018, the Group delivered another year of robust growth in
revenue and earnings benefiting from strong industrial economies in
the US and Europe and from the reduction in the US Federal
corporate income tax rate. The Group's reported revenues increased
by 7%, with currency headwinds decreasing revenues by 3% and
acquisitions, net of a small disposal this year, contributing 3% to
revenue growth. On an underlying basis, after adjusting for
acquisitions, the disposal and for the currency effects on
translation, Group revenues increased by 7%.
The Group's adjusted operating margins improved by 20bps to
17.5%, compared with 17.3% in the prior year and the first half of
the current year. Gross margins remained unchanged from last year,
despite pressures on supply chains in most Sectors leading to
increases in product costs and other margin support costs. These
pressures were mitigated during the second half of the year as
selective price increases began to take effect and with increased
availability of inventory. Adjusted operating costs as a percentage
of revenue have reduced by 20bps with improved operating leverage
from the increase in revenues and generally tight control of
operating costs.
Working capital as a percentage of revenue was managed down
through the second half of the year to 15.1%. The Group's free cash
flow increased by 9% to GBP60.5m, reflecting very strong cash
generation in the second half of the year and boosted by proceeds
of GBP4.0m from the disposal of a small non-core US business.
Sector performance
In Life Sciences, underlying revenues increased by 5% after
adjusting for currency movements and the prior year acquisition of
Abacus ALS. The Healthcare businesses benefited from strong
diagnostic consumable revenues and the introduction of new premium
Surgical and Endoscopy products. The Environmental businesses had a
mixed year with stronger revenues in Germany, offset by reduced UK
revenues because of delays in placement of orders. Both
Environmental businesses continued to benefit from stronger service
revenues.
In Seals, underlying revenues increased by 10% after adjusting
for currency movements, the prior year acquisitions of PSP and Edco
and the disposal of the small non-core Bulldog business this year.
In North America, both the Aftermarket and Industrial OEM business
benefited from a buoyant US industrial economy. In the
International Seals businesses, a strong improvement in industrial
activity in the second half of the year provided good growth in
European revenues. Solid growth in Australian revenues was more
than offset by much weaker trading with a major customer in New
Caledonia.
In Controls, underlying revenues increased by 5% after adjusting
for currency movements and the acquisitions this year of FS Cables
and Coast. The Interconnect revenues benefited from both broadening
its customer base deeper into Europe and from stronger industrial
markets. The Specialty Fasteners business also increased revenues
from broadening its range of customers in the Civil Aerospace
sector. The Fluid Controls businesses reported lower revenues
reflecting the decision to focus on higher margin business and from
the absence of a large one-off project delivered last year.
Acquisitions and disposals
Over the last five years, a total of ca. GBP128m has been
invested in acquisitions and ca. GBP6m has been realised from
divesting businesses.
During 2018, the acquisition spend was GBP20.4m of which
GBP16.9m was invested in the acquisition of FS Cables, a supplier
of specialist cable products to a range of industries and based in
St Albans, UK. FS Cables fits well within the Controls Sector
alongside Cablecraft, which was acquired in 2016 and provides
growth opportunities through cross selling to new and existing
customers. The small non-core US business, Bulldog, was sold during
2018 for cash proceeds of GBP4.0m.
In addition, the Group completed two smaller bolt-on
acquisitions in the Controls Sector: Coast, a small specialty
fastener distributor based in California, US was acquired in
October 2017 and Gremtek, a supplier of own-brand protective
sleeving products, based in France was acquired after the year end
in October 2018.
Strong Executive management
The Executive Management Committee ("EMC") comprises the
Executive Directors along with the Executive managers who are
responsible for the major business clusters and key Group
functions. The EMC members are a combination of internally
developed senior managers and experienced senior managers who have
been recruited externally.
The EMC has been strengthened this year with experienced senior
management who will take responsibility for overseeing and
coordinating additional Group functions, including IT and ERP
projects carried out across the Group. A HR senior manager is also
being recruited and will join the EMC in the new financial year.
The EMC provides the opportunity for members to broaden their
perspective of the Group's activities in order to reinforce the key
elements of the Group's culture and to identify best practices that
are transferable across the Group. The EMC meets quarterly through
a combination of full group meetings in London and sub-group
meetings held in the major business locations.
During this year, the EMC has demonstrated its strength by
providing a significant level of stability and support to the
businesses in a period of uncertainty caused by the change in CEO.
This has contributed to the strong results reported this year.
SECTOR DEVELOPMENTS
LIFE SCIENCES
The Life Sciences Sector businesses supply a range of
consumables, instrumentation and related services to the healthcare
and environmental industries.
2018 2017
Revenue GBP134.7m GBP125.9m +7%
Adjusted operating profit GBP23.9m GBP23.3m +3%
Adjusted operating margin 17.7% 18.5% -80bps
Free cash flow GBP17.3m GBP17.0m +2%
--------------------------- ----------- ---------- --------
-- Sector revenue growth of 7%; underlying growth of 5% after
adjusting for currency and an acquisition completed last year
-- In Canada, DHG underlying revenues increased by 8% with
strong consumable revenues from its leading products; the Surgical
and Endoscopy products lines at Vantage business reported strong
revenues from the introduction of new premium products
-- In Australia and New Zealand, underlying revenues increased
by 4%; Abacus ALS acquired in April 2017 reported strong growth
across its portfolio of products, which more than offset reduced
revenues in the Surgical Products business following the
acquisition of a key supplier by a large industry player
-- TPD revenues were broadly flat in Ireland and the UK with new
suppliers and product segments replacing suppliers moving to a
direct supply model
-- The Environmental businesses reported unchanged underlying
revenues with strong revenue growth in Germany, offset by reduced
revenues in the UK from delays in order placement
Reported revenues of the Life Sciences Sector businesses
increased by 7% to GBP134.7m (2017: GBP125.9m). The acquisition of
Abacus ALS, acquired in April 2017, incrementally added GBP6.4m or
5% to Sector revenues, which was partly offset by a headwind of 3%
from currency movements on translation of the results from overseas
businesses to UK sterling. After adjusting for currency effects and
this acquisition, underlying revenues increased by 5%.
Adjusted operating margins reduced by 80bps to 17.7% largely
reflecting the investment made during the year developing
opportunities for the new endoscopes introduced in Canada. DHG
margins were also diluted from a full year contribution, together
with one-off integration costs, of the combined diagnostic
businesses in Australia and New Zealand and weaker revenues
following a loss of a supplier in BGS. In addition, an increase in
underlying costs in the Environmental businesses on unchanged
revenues led to negative leverage. However gross margins improved
reflecting a more favourable mix of revenues in both the Healthcare
and Environmental business. Transactional currency pressures on the
Healthcare margins remained subdued, but favourable currency hedges
helped offset some volatility of the Canadian and Australian
dollars relative to the US dollar and Euro during the second half
of the year. Adjusted operating profits increased by 3% to GBP23.9m
(2017: GBP23.3m).
The Life Sciences businesses invested GBP3.5m (2017: GBP2.0m) in
new capital during the year of which GBP2.3m (2017: GBP1.6m) was
spent on acquiring field equipment for both new placements in
hospitals and laboratories and for loan equipment and demonstration
models to support existing placements. The increase in spend on
field equipment was largely driven by the launch of a new series of
flexible endoscopes, together with the addition of a range of rigid
endoscopes under a new supplier agreement. A further GBP0.6m was
invested in completing the refurbishment of the AMT and Vantage
office and service facilities in Kitchener and Markham, Canada and
on a new facility for a1-CBISS in the UK. The balance of GBP0.6m
was invested in warehouse equipment and on upgrading the IT
infrastructure in both businesses. Free cash flow increased
marginally to GBP17.3m (2017: GBP17.0m), reflecting reduced cash
flows into working capital, offset by higher capital
investment.
Healthcare
The DHG businesses, which account for 85% of Life Sciences
revenues, increased underlying revenues by 6% after adjusting for
currency effects and the incremental revenue from the acquisition
of Abacus ALS.
In Canada, underlying revenues increased by 8% against the
background of continuing budget pressures throughout the Provincial
healthcare systems, with Group Procurement Offices ("GPOs")
continuing to restructure and amalgamate, both nationally and
regionally.
Somagen's core Clinical Diagnostics business delivered an
underlying increase of 2% in revenues, with steady growth in
consumable and service revenues. Capital sales decreased reflecting
the impact of laboratory centralisation and reduced spending after
a "catch-up" in procurement last year, following the 2016 hospital
spending freeze in some Provinces. Demand for diagnostic testing
remained robust, particularly with a combination of strong growth
and contract extensions for cancer screening tests and growth from
new technology introduced in the areas of Autoimmunity. A long term
contract was renewed with a major supplier and an additional supply
agreement was gained during the year that will provide
opportunities for Somagen in the Microbiology market. Somagen has
also secured large Provincial contracts to provide colorectal
cancer screening products and services that are expected to ramp up
in the next financial year.
AMT and Vantage, the Surgical and Endoscopy businesses in
Canada, delivered strong growth in revenues, primarily driven by
the successful introduction and rebranding of a premium range of
rigid and flexible endoscopes and surgical instrument sets in
Vantage. These offer further growth potential in the Urology and
Gynaecology segments of the surgical market. The introduction of a
new series of endoscopes in early 2018 has also provided Vantage
with opportunities to replace existing customer supply contracts in
several Provinces. Strong growth was also achieved at AMT in the
supply of specialised instruments used in laparoscopic and other
minimally invasive surgical procedures. These growth initiatives
have diversified the revenue streams across both the core surgical
and GI businesses and mitigated the continuing pressures in the
electrosurgery and smoke evacuation businesses, where pricing has
now stabilised, albeit at lower levels. In October 2018, AMT
secured a new five year contract with a large GPO to provide
electrosurgical and smoke evacuation products.
In Australia, Diagnostic Solutions has been integrated into
Abacus ALS to form Abacus dx, a larger broader-based Clinical
Diagnostics, Life Science and Patient Simulation business,
supplying to both the public and private pathology laboratories and
to research and educational establishments across Australasia.
Abacus dx has delivered strong growth in revenues on a
like-for-like basis, despite the continuing consolidation of
testing within Clinical Diagnostics and expanded professional
procurement in the fragmented Life Sciences market. Abacus dx is
working closely with key suppliers to position itself strongly in
response to the
shift towards track based laboratory systems. BGS, the Surgical
Products business, reported a reduction in revenues as it struggled
with securing sales of new products introduced to replace
electrosurgical products from a supplier that had been acquired by
a larger industry player with its own channels to market. However
strong growth from key suppliers of other Surgical Products helped
mitigate some of the shortfall. In smoke evacuation, the
implementation of nursing guidelines enforcing smoke evacuation
compliance will drive longer term growth, but has also slowed
evaluation and decision processes during the year.
The TPD business in Ireland and the UK reported revenues broadly
flat in Euro terms, as it managed the transition of a number of
suppliers who have moved from specialised distribution to a direct
supply model. New suppliers have been secured that will help
mitigate this transition, together with solid growth within the
Clinical segment supplying clinical chemistry and serology control
products. New suppliers and businesses providing agitators and
separators used in the NHS Blood and Transplant service continued
to diversify the breadth of the portfolio. The Biotechnology and
Service segments also delivered good growth from strong capital
sales, which reflected management's efforts to forge strong
strategic partnerships with their diverse customer base both in
Ireland and the UK. TPD is further broadening its service
capability beyond diagnostic instrumentation and has established a
new Surgical Products division to bring to market the
electrosurgical and smoke evacuation products similar to those
supplied by AMT and BGS in Canada and Australia, respectively.
Environmental
The a1-group of Environmental businesses in Europe, which
account for 15% of Life Sciences revenues, saw revenues increase by
1% in UK sterling terms, but remained unchanged in constant
currency terms.
The a1-envirosciences business based in Germany increased
revenues by 7% in Euro terms driven by strong demand in Germany for
high-end halogen analysers and increased sales of customised
containment enclosures. The increasing environmental awareness and
in particular, the anticipated regulations on toxic polyfluorinated
compounds, found in a range of man-made products, is creating
demand for these analysers in R&D and Environmental control.
Health & Safety regulations continue to increase demand for
customised containment enclosures for the safe weighing of
hazardous materials. The business is also targeting investment in
service personnel to support the larger installed base and demand
from customers for faster response times. In addition, investment
is being made in an IT based field service management system to
enhance customer service and improve efficiency of its growing
service team.
The a1-CBISS business based in the UK reported an 8% decrease in
revenues reflecting significant delays during the year in order
placement for continuous emissions monitoring systems ("CEMS").
However the opportunities in this sector remain encouraging with
new Energy from Waste ("EFW") plants playing an important role in
reducing landfill waste. Revenue from service contracts continues
to grow as EFW plants supplied over the last 18 months become
operational.
SEALS
The Seals Sector businesses supply a range of seals, gaskets,
filters, cylinders, components and kits used in heavy mobile
machinery and specialised industrial equipment.
2018 2017
Revenue GBP208.0m GBP195.3m +7%
Adjusted operating profit GBP36.0m GBP31.9m +13%
Adjusted operating margin 17.3% 16.3% +100bps
Free cash flow GBP25.9m GBP24.9m +4%
--------------------------- ---------- ---------- ---------
-- Sector revenue growth of 7%; underlying growth of 10% after
adjusting for currency and the net impact from acquisitions and a
disposal completed during the past two years
-- In North America, Aftermarket underlying revenues increased
by 9% driven by strong markets in the core Hercules business and
continued robust growth in the HKX business
-- Industrial OEM underlying revenues in North America increased
by 13% in a very strong US Industrial market, supported by healthy
manufacturing PMI data
-- Implementation of a new ERP system in the Industrial OEM
businesses in the US, following the establishment of a senior
management team last year to manage this cluster of businesses
-- International Seals businesses increased underlying revenues
by 7% with stronger trading across all businesses in the second
half of the year
Reported revenues of the Seals Sector businesses increased by 7%
to GBP208.0m (2017: GBP195.3m). The acquisitions of PSP and Edco
completed in 2017, net of a small disposal this year, contributed
GBP3.3m or 2% to Sector revenues, but this was more than offset by
currency movements on translation of the results from overseas
businesses to UK sterling, which reduced Sector revenues by 5%.
After adjusting for the acquisitions and for currency effects,
underlying revenues increased by 10%.
Adjusted operating margins for the Sector increased by 100bps to
17.3% (2017: 16.3%) with stronger revenues providing operating
leverage. This more than offset a small reduction in gross margins
arising from both a lag in the first half of the year in passing on
supplier price increases and increased freight costs from
expediting inventories. Adjusted operating profits increased by 13%
to GBP36.0m (2017: GBP31.9m).
During the year, GBP2.0m (2017: GBP1.1m) of capital expenditure
was invested in the Seals businesses. This primarily comprised
GBP1.1m on implementing a new single ERP system across the US
Industrial OEM businesses and a new ERP system in Kentek. A further
GBP0.9m was spent on upgrading warehouse equipment and facilities
and on the general IT infrastructure across the Seals businesses.
The free cash flow generated in this Sector increased by GBP1.0m to
GBP25.9m, with stronger operating cash flow being partly absorbed
by higher working capital to support the strong trading
environment.
North American Seals
The North American Seals businesses, which account for 60% of
Seals revenues, reported revenues up 6% on the prior year.
Underlying revenues increased by 11% after adjusting for the
strengthening of UK sterling against both the US and Canadian
dollar, for the disposal of a small non-core business in June and
the bolt-on acquisition of PSP completed last year.
The HFPG Aftermarket businesses increased revenues by 9% on a
constant currency basis, driven by strong trading conditions in the
core Hercules business in both the US and Canada and continued
robust growth in the HKX attachment kit business. There was
significant pickup in activity in the Oil & Gas sector and both
new Construction and large Infrastructure projects led to increased
demand for heavy machinery that required increased servicing and
repair. The significant increase in activity has led to extended
lead times in the supply chain and robust supplier price increases,
which HFPG has sought to mitigate through increased catalogue
prices.
In the domestic US market, Hercules revenues increased by 9%
with the Repair and Distributor segments growing steadily through
the year reflecting higher equipment levels. With seal
manufacturers struggling to keep up with demand, Distributors
turned to Hercules for their superior service and inventory
availability. Hercules continue to add products to their portfolio
and broaden the scope of equipment supported to include
Aerial-Lifts, Logging, Injection Moulding and Agriculture.
Investment was also made to enhance existing sales resources and
extend into new territories. New market opportunities include seal
kitting services for industrial plants of OEMs. E-commerce
continues to deliver strong year-on-year growth and now accounts
for 30% of invoices processed and 25% of Hercules US revenues.
Enhancements were made to the E-commerce functionality to allow
customers to configure custom seals and provide access via mobile
applications.
The core Hercules business in the US has also made good progress
in developing a major project to invest ca. US$10m in a second
warehouse facility to provide capacity to meet the growing demand
for a broader range of products, as well as gain greater access to
expanded territories in the US. Potential facilities have been
identified and work on this project will commence in 2019 with the
aim of becoming fully operational in the 2020 financial year.
In Canada, revenues increased by 7% in local currency terms,
supported by a robust Construction sector with increased
residential housing starts driving growth in the repair market.
Non-residential construction also grew with several new mining
projects and demand for additional warehouse facilities. Robust
industrial markets had a positive impact on revenues from sales to
OEM cylinder manufacturers.
In markets outside of North America, Hercules achieved a
double-digit increase in revenues from sales in Colombia and Chile
and record sales to the Rest of World, including China.
The HKX attachment kit business has continued to benefit from
tight availability of OEM excavator equipment. In this environment
revenues increased by 13%, with strong demand for Tier 3 machines
in Canada (ahead of the Tier 4 mandate on 1 January 2019).
In June 2018, Hercules sold its small Bulldog gasket business at
net asset value for cash consideration of GBP4.0m as it was no
longer a core part of the Hercules business.
The HFPG Industrial OEM businesses in North America increased
revenues by 13% in a very strong US industrial market, supported by
healthy Manufacturing PMI data. The business has a number of large
key accounts across a range of specialised industrial applications
in industries including Water, Medical, Oil & Gas, Fluid
Handling and Food Equipment. Good double-digit growth was achieved
in all these accounts through deeper and broader penetration to
identify additional value-adding opportunities. The businesses
continue to provide high levels of customer service and technical
support to service existing projects, while looking for
opportunities to deploy higher specification, regulatory-compliant
compounds, to target new projects with higher levels of
added-value.
A constant challenge during the year was managing supplier price
increases against a background of generally annual customer supply
agreements, particularly with the larger key accounts. The
introduction of US tariffs towards the end of the financial year
has initially also led to some pressure on gross margins, as
existing inventory works through. Tariff charges are now being
passed on to customers in the form of a separate line charge and
selling prices will be updated as supply agreements are
renewed.
The Industrial OEM Seals businesses now comprise a cluster of
businesses led by a single senior management team directing the key
functions of Sales, Supply Chain, Technical and Finance, while
maintaining the distinct identity of each business. This has
provided the opportunity to realign sales resources and consolidate
the supply chain and finance functions within one back office. A
key and necessary part of this exercise was the implementation of a
new ERP system to replace the disparate legacy IT systems in the
businesses. The new ERP system, which went live shortly after the
year end, will increase operational efficiency and improve business
intelligence to allow field sales to focus on higher margin market
segments and products. These initiatives will be supported by new
branding and through strategic advertising and trade shows.
International Seals
The International Seals businesses, which account for 40% of
Seals revenues, reported a 7% increase in UK sterling terms,
benefiting from substantially stronger revenues in the second half
of the year. After adjusting for currency effects, the impact from
the disposal of the Bulldog business on FPE revenues and the
acquisition of Edco completed last year, underlying revenues were
also up 7%. During the year the International Seals cluster of
businesses strengthened management, set up projects to implement
new ERP systems in 2019 and shared best practice in developing
E-commerce functionality across the businesses.
The FPE Seals and M Seals businesses, with their principal
operations in the UK, Scandinavia and the Netherlands, together
delivered underlying growth of 6% in revenues on a constant
currency basis and after adjustment for the acquisition of Edco and
disposal of Bulldog. The FPE Seals business delivered modest
underlying revenue growth, despite robust growth in its core UK
Aftermarket hydraulic seals and cylinder parts business and a
strong improvement in the Oil & Gas market. This was offset by
weaker international sales reflecting the absence of a large export
order delivered last year. Sales coverage has now been realigned to
focus on account management and the existing capacity for the
production of machined seals will be utilised to help penetrate the
small OEM and Repair businesses outside the hydraulic cylinder
market.
M Seals continued to deliver good growth in revenues from its
core markets driven by strong customer relationships that have
provided a number of major new projects, particularly in Sweden. As
with FPE Seals, M Seals has also benefited in the UK from the
recovery in the Oil & Gas market with customers expanding
activities and providing good growth in revenues. In its first full
year with the Group, Edco (now collectively branded M Seals UK)
delivered good growth in revenues on a like-for-like basis, with
increased sales to key customers.
Kubo, which operates in Switzerland and Austria, increased
underlying revenues by 13%, benefiting from strong industrial
production driven by increased exports and supported by the
depreciation of the Swiss franc. Customers and suppliers reported
full order books with production capacity at high levels. Kubo
continues to target smaller manufacturing plants focused on Life
Sciences, Biotechnology and Microelectronics where Kubo's
specialised products and technical knowledge can add value to the
customer. During the year, Kubo gained a large new distribution
supply contract representing a pan European manufacturer that will
provide further opportunity for growth next year. The market in
Austria has also been buoyant and Kubo has continued to increase
revenues from existing and new customer contracts.
The Kentek business, with principal operations in Finland and
Russia, increased revenues by 1% in Euro terms, despite the
significant impact on the region from the EU/US sanctions regime.
Revenues generated in Russia, which account for ca. 65% of Kentek
revenues, improved strongly in the second half of the year, after a
weak first half, supported by stronger global Oil & Gas
markets. Kentek has also benefited significantly from expanding its
own-brand filter range and from widening its geographical coverage
towards eastern Russia. In Finland, revenues increased with sales
targeted to support projects in the large Industrial OEM
sector.
WCIS has core capabilities in industrial gaskets and mechanical
seals used in MRO operations in complex, high specification and
arduous conditions. Revenues were negatively impacted this year by
cost reduction initiatives in the nickel mining and processing
operations of its major customer in New Caledonia. This more than
offset strong growth in Australian revenues as new contracts were
gained in the Power Generation sector and as Mining activity
continued to improve with repairs of customer assets. WCIS
continues to broaden its coverage across a wider range of products,
market sectors and regional territories.
CONTROLS
The Controls Sector businesses supply specialised wiring, cable,
connectors, fasteners and control devices used in a range of
technically demanding applications.
2018 2017
Revenue GBP142.4m GBP130.7m +9%
Adjusted operating profit GBP25.0m GBP23.0m +9%
Adjusted operating margin 17.6% 17.6% -
Free cash flow GBP19.8m GBP18.6m +6%
--------------------------- ---------- ----------- ----
-- Sector revenue growth of 9%; underlying growth of 5% after
adjusting for currency and acquisitions completed this year
-- The Interconnect businesses delivered underlying growth of
7%; the FS Cables acquisition brings a range of own-branded
specialist wire and cable products
-- Clarendon increased underlying revenues by over 8%, with
growth driven by broadening its range of customers in Civil
Aerospace; US market targeted through the acquisition of Coast
-- Fluid Controls revenues reduced by 4% reflecting the decision
to focus on higher margin business and the absence of a large
one-off project
Reported revenues of the Controls Sector businesses increased by
9% to GBP142.4m (2017: GBP130.7m). The acquisitions of Coast,
acquired in October 2017 and FS Cables, acquired in August 2018,
added GBP5.1m or 4% to Sector revenues. After adjusting for
negligible currency movements on revenues from translation to UK
sterling and for these acquisitions, underlying Sector revenues
increased by 5%, with activity in the final quarter particularly
robust in what is normally a slower summer period.
Adjusted operating margins were unchanged at 17.6% (2017:
17.6%). Gross margins improved overall reflecting a stronger
customer mix in Clarendon, the absence in Fluid Controls of a large
low margin project last year, together with a focus away from lower
margin air conditioning business. In Interconnect, stronger gross
margins in the Cablecraft business offset the impact of strategic
pricing used selectively by the IS-Group to penetrate new customers
within the broader European region. Investment in sales resources
to drive growth for Clarendon in the US and to enhance E-commerce
at Cablecraft contributed to an increase in operating costs ahead
of revenue. Adjusted operating profits increased by 9% to GBP25.0m
(2017: GBP23.0m).
Capital expenditure in Controls increased to GBP1.1m (2017:
GBP0.2m), with GBP0.7m invested in the IS-Sommer freehold facility
to expand the existing warehouse and office capacity. A further
GBP0.4m was invested in small refurbishment projects at both
Cablecraft and Clarendon's newly acquired US facility and in
product testing equipment in the UK businesses. Free cash flow
increased by 6% to GBP19.8m (2017: GBP18.6m) reflecting stronger
trading and the additional contribution from the acquisitions,
partly offset by higher capital expenditure.
Interconnect
The Interconnect businesses account for 59% of Controls revenues
and reported an increase in revenues of 9% in UK sterling terms.
After adjusting for the FS Cables acquisition and for currency
effects, underlying revenues increased by 7% with good growth in
the IS-Group and Cablecraft, more than offsetting the absence of
major project activity in Filcon.
The IS-Group's UK businesses reported a 18% increase in revenues
reflecting good success achieved in broadening its customer base
across the broader European region, through directly targeting
cable harness houses, as well as supplying the traditional network
of European sub-distributors. In Aerospace and Defence, the UK
businesses reported a strong increase in revenues supported by high
value repeat orders and new project wins to expand market share.
New projects included the design-in of manufactured cables into the
KC-46 refuelling tanker, as well as harness components used on the
"Crowsnest" Merlin helicopter and the Ajax armoured fighting
vehicle. An active Industrial sector also contributed to a strong
growth in revenues from a broad range of end-users. In Energy, the
recovery in the oil price has led to renewed activity with demand
for products going into subsea applications and Tier 4 engines used
in the global fracking and mining industries. In Motorsport,
revenues were flat on the prior year with a much quieter year for
development in Formula 1, WRC and the America's Cup, but were
partly compensated by additional activity in Formula E.
The IS-Group's German business, IS-Sommer, delivered 12% growth
in revenues with particularly strong performances in the Aerospace,
Defence and Industrial markets. A new distribution agreement was
concluded during the year with a leading manufacturer of specialist
aviation cables, which boosted Aerospace growth. Defence revenues
benefited from supplying into new programmes to refit and refurbish
Leopard II tanks and Boxer armoured vehicles, as well as the
ongoing programme to produce Boxer armoured vehicles for the
Lithuanian military. Industrial revenues benefited from the
strength of the export led German economy. Medical revenues
continued to benefit from design-in efforts initiated in earlier
years to help manufacturers manage strict new European regulations
for medical devices. Motorsport sales remained depressed as a
result of the withdrawal of Audi and Volkswagen from the German DTM
series. IS-Sommer was also successful in extending its distribution
contract with its main supplier of Energy tubing products to a much
larger region within Germany, which will provide additional
opportunities for growth.
Following over 30% revenue growth last year, Filcon had a tough
year with a 26% decrease in revenues due to the absence of major
project activity, as well as much lower Motorsport sales following
the withdrawal of Audi and Porsche from the Le Mans series and
Volkswagen from the World Rally Championship.
Cablecraft reported a 5% increase in revenues as it continued to
target new end-user customers including panel builders, switchgear
manufacturers, Industrial OEMs and Contractors. During the year the
business also focused on substantially refreshing its brand
offering and marketing strategy, to be supported by the launch of
an enhanced E-commerce website in the first quarter of the new
financial year to target a broader range of customers in both the
UK and overseas. The facility was also upgraded, creating an
expanded and more efficient sales office and relocating the
Identification Solutions department to an improved environment that
will help drive future growth.
In August 2018, the Group acquired FS Cables, an established and
leading supplier of specialist cable products to installers,
end-users and wholesalers for a range of industries including
Electrical Contracting, Home Automation and Building Management,
Rail, Marine and Telecommunications. Based in St Albans, the
business primarily supplies own-branded products, which are sourced
from a portfolio of long-standing suppliers. These products
complement Cablecraft's range of cable accessory products and will
provide cross-selling opportunities to both businesses.
After the year end, in October 2018, the IS-Group acquired
Gremtek, a long established and leading supplier of own branded
protective sleeving and cable identification products to a broad
range of industrial markets principally in France, but also in
Germany and elsewhere in Europe. Gremtek's principal location is in
Paris, France, supported by a facility in Quickborn, Germany. The
business will be integrated into the IS-Group to support the
strategy of developing a broader Interconnect business across
Europe.
Specialty Fasteners
The Clarendon Specialty Fasteners business now accounts for 21%
of Controls revenues. The acquisition in the US of Coast
Fabrication Inc (rebranded Clarendon Specialty Fasteners Inc) in
October 2017 contributed to a 25% increase in revenues. After
adjusting for this acquisition, underlying revenues increased by 8%
with growth driven principally from increased demand from customers
in a buoyant Civil Aerospace sector. In this sector Clarendon
continued to broaden its customer base of major aircraft seating
and cabin interior manufacturers and their subcontractors across
Europe and Asia. Clarendon supports its major customers by
supplying its product through its automatic inventory replenishment
system ("Clarendon AIR"). During the year, the number of sites
operating this system doubled, enabling Clarendon to better service
these customers' requirements and providing opportunities for
further growth.
In Clarendon's other major market of Motorsport, underlying
revenue growth from Formula 1 customers was held back by the
absence of any major rule changes in 2018. However, new revenue
opportunities arose in projects undertaken for "supercar"
development with major automotive OEMs. Good revenue growth was
also achieved in the supply of preassembled and captive fasteners
and bespoke engineered solutions to the Defence and Industrial
sectors.
The US business acquired at the beginning of the year has made a
good contribution, with particular success in the Space Technology
sector. The US business also provides a base to build on the
success Clarendon has achieved in the aircraft cabin interiors
market in Europe by targeting the US based manufacturers and their
subcontractors. The strong Motorsport focus complements Clarendon's
existing Motorsport customer base and provides opportunities to
increase market share from a more focused sales approach. During
the year, investment was made to strengthen sales resources,
refurbish the facility and upgrade IT systems to provide a platform
for growth.
Fluid Controls
The Hawco Group of Fluid Controls businesses accounts for 20% of
Controls revenues and supplies temperature, pressure and fluid
control products, principally to the Food & Beverage industry.
Revenues decreased by 4% against the prior year reflecting the
absence of a large one-off project delivered last year and the
decision to focus on higher margin products and pull-back from the
highly price competitive air conditioning business.
Hawco experienced a challenging year with weaker activity in the
OEM Refrigeration equipment market as key accounts suffered from a
softer UK Food Retail market, caused by the low level of new store
openings. Sales to the hospitality trade also slowed as chains
embarked on programmes to rationalise branches and cannibalise
equipment. In the Contractor market, revenues decreased as Hawco
focused on the higher margin products and pulled back from the
lower margin air conditioning and cold-room business. However,
revenues from the Industrial OEM market increased through a focus
on core product lines and on developing broader export markets.
Abbeychart reported strong trading in its core markets, although
revenue growth was held back by the absence of a large one-off
project delivered last year refreshing a range of vending machines.
After adjusting for this project, Abbeychart achieved strong
revenue growth by focussing on its value added services, such as
refurbishment, kitting and assemblies and through improved
marketing. In particular, good growth was achieved in the Water,
Vending and Soft Drinks sectors where Abbeychart continues to take
market share. Abbeychart also continues to strengthen its
relationships with key vending machine operators in Europe through
the supply of its range of spare parts for Wurlitzer vending
machines.
FINANCE REVIEW
Reported and underlying results in 2018
Reported revenues increased by 7% to GBP485.1m and adjusted
operating profit increased by 9% to GBP84.9m, with each Sector
benefiting from a favourable macro-economic environment leading to
robust customer demand in all geographies.
A recovery this year in UK sterling, particularly in the first
half of the year, led to a currency headwind of 3% on the
translation of the results of the overseas businesses, when
compared with last year's average exchange rates. This currency
headwind led to a reduction in revenues and adjusted operating
profits of GBP13.1m and GBP2.4m, respectively. Acquisitions
completed this year and last year, net of a small disposal this
year, incrementally contributed GBP14.8m and GBP2.1m to revenue and
adjusted operating profit, respectively.
The underlying results present the performance of the Group on a
like-for-like basis by adjusting for the contribution from
businesses acquired during the year (and from the incremental
impact from those acquired last year) and for the impact on the
translation of the results of the overseas businesses from the
strengthening in the UK sterling exchange rate, against most of the
currencies of the Group's overseas businesses. With the currency
headwind being broadly offset by the incremental contribution from
acquisitions (net of a small disposal), underlying revenues and
underlying adjusted operating profits also increased by 7% and 9%,
respectively.
Adjusted operating margin
The Group's adjusted operating margin improved by 20bps this
year to 17.5% (2017: 17.3%) reflecting the benefit of operational
leverage, with Group gross margins remaining unchanged from last
year.
In Life Sciences, gross margins strengthened slightly,
reflecting a more favourable product mix and a small net currency
transactional benefit from movements in exchange rates. The
Canadian and Australian exchange rates have generally remained more
stable this year and the benefit of favourable currency hedge
contracts made a positive contribution. In Seals, gross margins
slightly weakened as buoyant markets led to supplier price
increases and longer product lead times. These price increases were
generally not passed through to customers until the second quarter
of the financial year. Freight costs also increased to mitigate
longer lead times and maintain service levels to customers. In
Controls, gross margins improved reflecting the benefit from a
favourable product mix, proactive and targeted price increases and
a decision to pull-back from lower margin sales opportunities.
Adjusted and statutory profit before tax
Adjusted profit before tax increased by 9% to GBP84.8m (2017:
GBP77.5m). The interest expense this year was GBP0.1m (2017:
GBP0.7m) and comprised the interest expense on the Group's net
pension deficit, which had reduced from GBP0.3m last year,
reflecting the smaller deficit in the fund at the beginning of this
year.
There were no borrowing costs this year (2017: GBP0.1m) as the
Group held cash funds for the majority of the year and interest
earned on these cash funds of GBP0.1m offset bank facility
commitment fees of GBP0.1m (2017: GBP0.3m). Last year's facility
fees included a GBP0.2m arrangement fee on renewal of the bank
facility.
Statutory profit before tax was GBP72.7m (2017: GBP66.8m) and is
after charging acquisition related charges of GBP9.6m (2017:
GBP9.7m) (which largely comprise the amortisation of acquisition
related intangible assets) and fair value remeasurements of GBP0.4m
(2017: GBP1.0m). In addition, one-off CEO transition costs of
GBP2.1m were incurred relating to the change of the CEO in the
current year.
The CEO transition costs comprise those charges directly
attributable to the change, after 22 years, in the leadership of
the Group this year. In particular, it includes the costs of
recruitment, the costs of employment of the new CEO and the costs
of the financial settlement relating to his departure from the
Company on 28 August 2018, including advisors costs. These costs
are set out in note 15 to the consolidated financial statements.
The full year employment costs of Bruce Thompson, the retiring CEO,
have been charged against adjusted operating profit and are not
included in CEO transition costs.
The charge attributable to fair value remeasurements relate to
the put options held over minority interests as described further
below.
Tax charge, earnings per share and dividends
The Group's effective tax charge on adjusted profit reduced by
260bps in 2018 to 23.9%, compared with 26.5% last year. This lower
rate reflected the impact from the reduction in the US Federal
corporate income tax rate to 21% from 35%, effective 1 January
2018. The adjusted profit before tax earned in the US accounts for
ca. 26% of Group adjusted profit before tax.
Adjusted earnings per share ("EPS") increased by 13% to 56.4p,
compared with 49.8p last year and statutory EPS increased by 13% to
47.5p (2017: 42.0p).
The Board continues to pursue a progressive dividend policy that
aims to increase the dividend each year broadly in line with the
growth in adjusted EPS. In determining the dividend in any one
year, the Board also considers a number of factors which include
the strength of the free cash flow generated by the Group, the
future cash commitments and investment needed to sustain the
Group's long term growth strategy and the target level of dividend
cover. The Board continues to target towards two times dividend
cover (defined as the ratio of adjusted EPS to total dividends paid
and proposed for the year), which provides a prudent buffer. The
ability of the Board to maintain future dividend policy will be
influenced by the principal risks identified on pages 18 to 22 that
could adversely impact the performance of the Group.
For 2018, the Board has recommended a final dividend of 17.8p
per share (2017: 16.0p) making the proposed full year dividend
25.5p (2017: 23.0p). This represents an 11% increase in the
proposed full year dividend with dividend cover remaining unchanged
at 2.2 times.
Free cash flow
Free cash flow represents cash available to invest in
acquisitions or return to shareholders. The Group again generated
strong free cash flow this year of GBP60.5m (2017: GBP55.7m), which
benefited from GBP4.0m received on the sale of the small non-core
US business. The free cash flow conversion was 95% (2017: 99%) of
adjusted earnings.
The Group's operating cash flow increased by GBP5.0m to GBP84.3m
(2017: GBP79.3m) this year, broadly reflecting the increase in
operating profit. As anticipated in the Half Year Report, the
outflow of cash into working capital improved substantially in the
second half of the year to GBP5.1m (2017: GBP4.0m) from GBP11.2m at
31 March 2018. Inventories increased by GBP8.3m (2017: GBP5.1m) to
meet the stronger trading environment, particularly in the Seals
businesses. This was partly offset by an inflow of GBP3.2m (2017:
GBP1.1m) from an increase in net payables at the year end. The
Group's KPI metric of working capital to revenue at 30 September
2018 remained broadly unchanged from last year at 15.1% (2017:
15.0%), again reflecting the robust revenues over the previous
rolling 12 months.
Group tax payments decreased by GBP0.3m to GBP19.0m (2017:
GBP19.3m). On an underlying basis cash tax payments represented ca.
23% (2017: 24%) of adjusted profit before tax reflecting the
benefit from the lower US Federal corporate income tax rate.
Underlying tax payments are before currency effects from
translation and exclude payments for pre-acquisition tax
liabilities in acquired businesses.
The Group's tax strategy is to comply with tax laws in all of
the countries in which it operates and to balance its
responsibilities for managing tax, with its responsibility to pay
tax where it does business. The Group's tax strategy and policies
have been approved by the Board this year and tax risks are
regularly reviewed by the Audit Committee.
The Group's capital expenditure doubled this year to GBP6.6m
(2017: GBP3.3m) reflecting in part the impact from new field
equipment introduced in the Healthcare businesses and in part
investment required in facility and IT infrastructure across the
Group to support the increased trading activity seen over the past
two years.
The Life Sciences businesses invested GBP3.5m in new capital
this year (2017: GBP2.0m) of which GBP2.3m (2017: GBP1.6m) was
invested in field equipment in the Healthcare businesses to support
placements of new surgical equipment in hospitals and diagnostic
machines in laboratories. A further GBP0.6m was invested in
expanding and refurbishing facilities and offices in both the
Healthcare and Environmental businesses and the remaining GBP0.6m
on both warehouse equipment and on upgrading the IT
infrastructure.
The Seals businesses invested GBP2.0m (2017: GBP1.1m), with
GBP1.5m in the North American Seals businesses and GBP0.5m in the
International Seals businesses. The new ERP systems being
implemented in both the US Industrial OEM Seals business and in
Kentek accounted for GBP1.1m and GBP0.8m was spent on refurbishing
facilities and on warehouse equipment. The remaining GBP0.1m was
spent on upgrading the IT infrastructure across the Seals
Sector.
In the Controls businesses GBP1.1m (2017: GBP0.2m) was invested
primarily in expanding and refurbishing existing facilities. In
particular the German business, IS-Sommer, invested GBP0.7m on
expanding its existing warehouse and offices in Stuttgart, which is
expected to be completed for a total cost of ca. GBP1.6m in March
next year. The remaining GBP0.4m was spent on refurbishing the
facilities in Cablecraft and Coast.
The Company paid the PAYE income tax liability of GBP1.0m (2017:
GBP0.7m) on the exercise of LTIP share awards in November 2017, in
exchange for reduced share awards to participants. In addition,
GBP1.2m was paid to the Employee Benefit Trust to fund the
acquisition of 100,000 ordinary shares in the Company to meet
incentive awards.
The Group spent GBP20.4m (2017: GBP20.1m) of free cash flow on
acquisitions, including GBP2.0m on acquiring outstanding minority
shareholdings, as described below and GBP27.0m (2017: GBP23.7m) on
paying dividends to both Company and minority shareholders.
Acquisitions completed during the year
The Group invested GBP18.1m on acquiring new businesses this
year and paid a further GBP0.3m of deferred consideration on
businesses acquired in prior years. The continuing favourable
economic markets in the US and Continental Europe this year
contributed again to a much tougher environment to persuade
potential vendors to dispose of their companies. However there were
tentative signs towards the end of the year that, having enjoyed
several years of stronger trading and with uncertainty about the
future direction of global economies, some of these vendors were
returning to the M&A market.
In August 2018 the Group completed the acquisition of FS Cables,
based in St Albans, for GBP16.9m on a debt/cash free basis. FS
Cables is a leading supplier of specialist cable products to
installers, end-users and wholesalers for a range of industries.
The business complements the Group's existing Cablecraft business
acquired in 2016, which supplies cable accessory products used to
identify, secure and protect electrical cables. A further GBP1.2m
was spent in October 2017 to acquire Coast, a small specialty
fastener distributor based in California, US.
These acquisitions added GBP9.1m to the Group's acquired
intangible assets, which represents the valuation of customer and
supplier relationships that will be amortised over periods ranging
from five to ten years. At 30 September 2018, the carrying value of
the Group's acquired intangible assets was GBP53.6m and there was a
GBP9.3m charge this year to amortise these assets.
Goodwill at 30 September 2018 was GBP128.5m and included GBP5.7m
relating to those businesses acquired during the year (including
fair value adjustments to the assets acquired). Goodwill is not
amortised, but is assessed each year at a Sector level to determine
whether there has been any impairment in the carrying value of
goodwill acquired. The exercise to assess whether goodwill has been
impaired is described in note 10 to the consolidated financial
statements. It was confirmed that there was significant headroom on
the valuation of this goodwill, compared with the carrying value of
goodwill at the year end.
Shortly after the year end, the IS-Group acquired Gremtek, a
supplier of own branded protective sleeving products based in
France for GBP7.4m. This business will be integrated into IS-Group
to support their expansion into European markets.
Liabilities to minority shareholders
The Group's liability to purchase outstanding minority
shareholdings at 30 September 2018 reduced to GBP4.5m (2017:
GBP6.1m) following the purchase of the outstanding 10% minority
shareholding in TPD for GBP2.0m.
The minority shareholdings outstanding at 30 September 2018
relate to a 10% interest held in both M Seals and Kentek. The
options are exercisable in the next financial year.
The liabilities for these put options are valued based on the
Directors' latest estimate of the earnings before interest and tax
("EBIT") of these businesses when these options crystallise. A
charge of GBP0.4m (2017: GBP1.0m) has been included in finance
expense to reflect in part a slightly higher expected cost of
purchasing these minority interests and in part the unwinding of
the discount on the liability.
The Group also has a small liability at 30 September 2018 for
deferred consideration of up to GBP1.1m (2017: GBP0.5m), which
represents the Directors' best estimate of the amount likely to be
paid to the vendors of businesses purchased during the year, based
on the expected performance of these businesses during the
measurement period. During the year, GBP0.3m was paid as deferred
consideration relating to the acquisition of Ascome and Edco in
previous years and GBP0.2m, which was no longer required, was
released to the Consolidated Income Statement as part of
acquisition related charges.
Return on adjusted trading capital employed and capital
management
A key metric used to measure the overall profitability of the
Group and its success in creating value for shareholders is the
return on adjusted trading capital employed ("ROATCE"). At a Group
level, this is a pre-tax measure that is applied against the fixed
and working capital of the Group, together with all gross
intangible assets and goodwill, including goodwill previously
written off against retained earnings. At 30 September 2018, the
Group ROATCE remained comfortably ahead of our 20% benchmark and
improved to 24.5% (2017: 24.0%), which reflects the strong increase
in adjusted operating profit this year. Adjusted trading capital
employed is defined in notes 2 and 3 to the consolidated financial
statements.
The Group continues to maintain a strong balance sheet with cash
funds of GBP36.0m at 30 September 2018, compared with GBP22.3m last
year. Surplus cash funds are generally repatriated to the UK,
unless they are required locally to meet certain commitments,
including acquisitions.
The Group also maintains a three year revolving multi-currency
credit facility that expires on 1 June 2020, but has an option to
extend the facility up to 1 June 2022. The facility comprises a
GBP30m committed facility with an accordion option that allows the
Group to increase the commitment up to a maximum of GBP60m of
borrowings. These facilities have a ratchet margin ranging from
70bps to 115bps over LIBOR, depending on the ratio of EBITDA to net
debt. These bank facilities are primarily used to meet any
shortfall in cash to fund acquisitions.
Employee pension obligations
Pension benefits to existing employees, both in the UK and
overseas, are provided through defined contribution schemes at an
aggregate cost in 2018 of GBP3.1m (2017: GBP2.8m).
The Group maintains a small legacy closed defined benefit
pension scheme in the UK. A formal triennial funding valuation of
this scheme was carried out as at 30 September 2016 and reported a
funding deficit of GBP9.2m with a 75% funding level, which
reflected the impact of bond yields falling to a record low of 1.5%
at the valuation date. Since the valuation date, bond yields have
increased to 2.9% and investment returns have been strong, which
has led to a lower funding deficit. This deficit is being funded by
cash contributions of GBP0.5m (2017: GBP0.4m) paid by the Company
to the scheme. This contribution rate increases annually on 1
October by 2% with the objective of eliminating the deficit within
ten years.
During the year, the scheme trustees, with the support of the
Company, completed a buy-in of the pensioner liabilities existing
at 1 September 2018. The buy-in was completed on 28 September 2018
with Just Retirement Limited for a premium of GBP13.0m, which was
funded by the scheme, utilising substantial investment gains
realised on the scheme's growth assets.
A recent decision by the High Court has confirmed that pension
schemes will be required to equalise GMPs accrued between 1990 and
1997, between men and women. The UK scheme has not yet equalised
GMPs, although as only ca. 25% of the members were contracted out
of SERPS prior to 1997, the impact is unlikely to be material to
the schemes existing liabilities.
In Switzerland, local law requires Kubo to provide a
contribution based pension for all employees, which are funded by
employer and employee contributions. This pension plan is managed
for Kubo through a separate multi-employer plan of non-associated
Swiss companies, which pools the funding risk between participating
companies. In Switzerland, Kubo's annual cash contribution to the
pension scheme was GBP0.2m (2017: GBP0.2m).
Both the UK defined benefit scheme and the Kubo contribution
scheme are accounted for in accordance with IAS19 (Revised). At 30
September 2018 the aggregate accounting pension deficit in these
two schemes increased slightly by GBP0.6m to GBP10.5m with a
reduction of the deficit in the Swiss scheme, being more than
offset by an increase in the UK scheme deficit. The larger deficit
in the UK scheme is because the buy-in premium was larger than the
valuation of the corresponding liabilities; the Swiss scheme
benefited from a higher discount rate, which led to a reduction in
the scheme deficit. The gross aggregate pension liability in
respect of these two schemes at 30 September 2018 decreased by
GBP0.4m to GBP49.1m, which is funded by GBP38.6m of assets.
Potential impact of Brexit
At an operational level, the impact on the Group's businesses
from the current uncertainty over the process and timing of the
UK's exit from the European Union is not expected to be significant
in terms of the Group's overall profitability. UK based revenues
account for only 26% of the Group's overall revenues and the UK
businesses, as well as those based in Continental Europe, are
substantially "in country" industrial suppliers of goods with
limited cross border sales activity.
The Group's financial results may be impacted by macro-economic
instability arising from a delayed or disruptive exit from the
European Union, such as a depressed UK economy or a substantial
depreciation in UK sterling. In such a scenario, there may be a
reduction in the Group's UK revenues and operating profits,
although Group net assets would benefit from translating the
results of the Group's overseas businesses into UK sterling. It is
also likely that a depreciation in UK sterling would lead to
stronger inflation in supplier costs for the Group's
UK based businesses, which would need to be managed robustly to
maintain gross margins.
The Board will continue to monitor closely developments in the
Brexit plans on its UK businesses. A prolonged disruption at the
UK's borders has the potential to impact the supply chain of the
Group's UK businesses; however the businesses maintain a strong
depth of inventories and have begun to build inventory levels of
their faster moving product lines which would mitigate the impact
on their activities from a significant disruption in cross border
trade between the UK and Continental Europe.
PRINCIPAL RISKS AND UNCERTAINTIES
Set out below are the principal risks and uncertainties
affecting the Group that have been determined by the Board, based
on a robust risk evaluation process, that have the potential to
have the greatest impact on the Group's future viability. These
risks are similar to those reported last year, although with some
movement on the relative ranking of these risks. There were no new
Principal Risks identified from the review process carried out by
the Board this year.
The risks are each classified as either strategic, operational,
financial or accounting. The Group's decentralised operations with
different Sectors and geographical spread reduces the impact of
these principal risks.
The Board has also considered the risks associated with the UK's
vote to leave the European Union and this is explained above in the
Finance Review.
Strategic risk Relative movement to prior year
Downturn/instability in major Increase
markets
Risk description and assessment Mitigation
Adverse changes in the major The businesses identify key
markets in which the businesses market drivers and monitor the
operate can have a significant trends and forecasts, as well
impact on performance. The effects as maintaining close relationships
of these changes can be seen with key customers who may give
in terms of slowing revenue an early warning of slowing
growth, due to reduced or delayed demand.
demand for products and services,
or margin pressures due to increased Changes to cost levels and inventories
competition. can then be made in a measured
way to mitigate the effects.
A number of characteristics
of the Group's businesses moderate Significant global effects are
the impact of economic and business closely monitored to determine
cycles on the Group as a whole: any potential impact on key
markets.
* The Group's businesses operate in three differing
Sectors with different cyclical characteristics and
across a number of geographic markets.
* The global economic outlook was more uncertain
towards the end of the financial year.
* The businesses offer specialised products and
services, which are often specific to their
application; this offers a degree of protection
against customers quickly switching business to
achieve a better price.
* A high proportion of the Group's revenues comprise
consumable products that are purchased as part of the
customer's operating expenditure, rather than through
capital budgets.
* In many cases the products are used in repair,
maintenance and refurbishment applications, rather
than original equipment manufacturer.
-----------------------------------------------------------------
Strategic risk Relative movement to prior year
Supplier concentration/loss No change
of key suppliers
-----------------------------------------------------------------
Risk description and assessment Mitigation
For manufacturer-branded products, Long term, multi-year exclusive
there are risks to the business contracts signed with suppliers
if a major supplier decides with change of control clauses,
to cancel a distribution agreement where possible, included in
or if the supplier is acquired contracts for protection or
by a company that has its own compensation in the event of
distribution channels in the acquisition.
relevant market. There is also
the risk of a supplier taking Collaborative projects and relationships
away exclusivity and either maintained with individuals
setting up direct operations at many levels of the supplier
or appointing another distributor. organisation, together with
regular review meetings and
Currently no single supplier adherence to contractual terms.
represents more than 10% of
Group revenue and only five Regular review of inventory
suppliers represent more than levels.
2% each of Group revenue.
Bundling and kitting of products
Relationships with suppliers and provision of added value
have normally been built up services.
over many years and a strong
degree of interdependence has Periodic research of alternative
been established. The average suppliers as part of contingency
length of the principle supplier planning.
relationships in each of the
Sectors is over ten years. The businesses work very closely
with each of their suppliers
The strength of the relationship and regularly attend industry
with each supplier and the volume exhibitions to keep abreast
of activity generally ensures of the latest technology and
continuity of supply, when there market requirements/trends.
is shortage of product. The businesses also meet with
The success of the businesses key customers on a regular basis
depends significantly on representing to gain insight into their product
suppliers whose products are requirements and market development.
recognised in the marketplace
as the leading competitive brand.
If suppliers fail to support
these products with new development
and technologies, then our businesses
will suffer from reduced demand
for their products and services.
-----------------------------------------------------------------
Strategic risk Relative movement to prior year
Customer concentration/loss No change
of key customer(s)
-----------------------------------------------------------------
Risk description and assessment Mitigation
The loss of one or more major Specific large customers are
customers can be a material important to individual operating
risk. businesses and a high level
of effort Is invested in ensuring
The nature of the Group's businesses that these customers are retained
is such that there is not a and encouraged not to switch
high level of dependence on to another supplier.
any individual customer and
no single customer represents In addition to providing high
more than 4% of Sector revenue levels of customer service and
or more than 2% of Group revenue. value added activities, close
integration is established where
possible with customers' systems
and processes.
-----------------------------------------------------------------
Operational risk Relative movement to prior year
Cyber security/Information Technology/Business Decrease
interruption
-----------------------------------------------------------------
Risk description and assessment Mitigation
Group and operating business There is good support and back-up
management depend critically built into local IT systems
on timely and reliable information and the spread of businesses
from their IT systems to run with their own stand alone IT
their businesses. The Group systems also offers good protection
seeks to ensure continuous availability, from individual events. The
security and operation of those majority of businesses back-up
information systems. online data at least once a
Cyber threats to the businesses day to an offsite data storage
information systems have this centre.
year reduced, following action A member of the Executive Management
taken to strengthen the IT infrastructure Committee is responsible for
environment across the Group's ensuring each business in the
businesses. Group has a robust cybersecurity
Any disruption or denial of programme and reports twice
service may delay or impact a year to the main Board on
decision making through lack the status of cybersecurity
of availability of reliable across the Group. In addition,
data. Poor information dandling education/awareness of cyber
or interruption of business threats continues to ensure
may also lead to reduced service Group employees protect themselves
to customers. Unintended actions and Group assets. At 30 September
of employees caused by a cyber-attack 2018, the majority of businesses
may also lead to disruption, had achieved the UK Government
including fraud. endorsed Cyber Essentials accreditation;
In North American Seals, HFPG's it is expected that all businesses
Aftermarket business is operated will be fully accredited within
from a single warehouse based the next six months.
in Tampa, Florida which continues Business continuity plans exist
to be exposed to hurricanes for each business with ongoing
during the season from August testing.
to November.
-----------------------------------------------------------------
Operational risk Relative movement to prior year
Loss of key personnel Increase
-----------------------------------------------------------------
Risk description and assessment Mitigation
The success of the Group is Contractual terms such as notice
built upon strong, self-standing periods and non-compete clauses
management teams in the operating can mitigate the risk in the
businesses, committed to the short term. However, more successful
success of their respective initiatives focus on ensuring
businesses. As a result, the a challenging work environment
loss of key personnel can have with appropriate reward systems.
an impact on performance, for The Group places very high importance
a limited time period. on planning the development,
motivation and reward for key
The average length of service managers in the operating businesses
of the ca. 100 senior managers including:
in the Group is 11 years and
for all personnel in the Group * Ensuring a challenging working environment where
is consistently ca. 7 years. managers feel they have control over, and
responsibility for, their businesses.
The uncertainty this year relating
to the appointment and subsequent
departure of the Chief Executive * Establishing management development programmes to
Officer has led to some instability ensure a broad base of talented managers.
in management and employees
within the Group.
* Offering a balanced and competitive compensation
package with a combination of salary, annual bonus
and long term cash or share incentive plans targeted
at the individual business level.
* Giving the freedom, encouragement, financial
resources and strategic support for managers to
pursue ambitious growth plans.
-----------------------------------------------------------------
Operational risk Relative movement to prior year
Product liability No change
-----------------------------------------------------------------
Risk description and assessment Mitigation
There is a risk that products Technically qualified personnel
supplied by a Group business and control systems are in place
may fail in service, which could to ensure products meet quality
lead to a claim under product requirements. The Group's businesses
liability. The businesses, in are required to undertake Product
their terms and conditions of Risk assessments and comprehensive
sale with customers, will typically Supplier Quality Assurance assessments.
mirror the terms and conditions The Group has also established
of purchase from the suppliers. Group-wide product liability
In this way the liability can insurance which provides worldwide
be limited and subrogated to umbrella insurance cover of
the supplier. GBP30m across all Sectors.
If a legal claim is made it The Group's businesses have
will typically draw in our business undergone product liability
as a party to the claim and training and are continually
the business may be exposed reviewed to demonstrate compliance
to legal costs and potential with Group policies and procedures
damages if the claim succeeds relating to product liability.
and the supplier fails to meet
its liabilities for whatever
reason. Product liability insurance
can be limited in terms of its
scope of insurable events, such
as product recall.
In situations where a Group
business is selling own-branded
products and cannot subrogate
the liability to a supplier,
the business will be liable
for failure of the product.
A Group business may also be
liable for the associated costs
of a subsequent customer recall
arising directly from failure
of an own-branded product.
-----------------------------------------------------------------
Financial risk Relative movement to prior year
Foreign currency No change
-----------------------------------------------------------------
Risk description and assessment Mitigation
Foreign currency risk is the The Group operates across a
risk that currency rates will number of diverse geographies
affect the Group's results. but does not hedge translational
The Group is exposed to two exposure of operating profit
types of financial risk caused and net assets.
by currency volatility: translational
exposure, being the effect that The Group's businesses may hedge
currency movements have on the up to 80% of forecast (being
Group's financial statements a maximum of 18 months) foreign
on translating the results of currency transactional exposures
overseas subsidiaries into UK using forward foreign exchange
sterling; and transactional contracts.
exposure, being the effect that
currency movements have on the The Group finance department
results of operating businesses monitors rolling monthly forecasts
because their revenues or product of currency exposures.
costs are denominated in a currency
other than their local currency. Details of average exchange
rates used in the translation
The Group operates internationally of overseas earnings and of
and is exposed to translational year-end exchange rates used
foreign exchange risk arising in the translation of overseas
from various currency exposures, balance sheets, for the principal
primarily with respect to the currencies used by the Group,
US dollar, the Canadian dollar, are shown in note 16 to the
the Australian dollar and the consolidated financial statements.
Euro. The results and net assets
of the Group's operations outside
the UK are also exposed to foreign
currency translation risk.
A strengthening of UK sterling
by 10% against all the currencies
in which the Group does business,
would reduce adjusted operating
profit before tax by approximately
GBP6.5m (8%), due to currency
translation. Similarly, a strengthening
of UK sterling by 10% against
all the non-UK sterling capital
employed would reduce shareholders'
funds by GBP20.4m.
The Group's UK businesses are
exposed to transactional foreign
exchange risk on those purchases
that are denominated in a currency
other than their local currency,
principally US dollars and Euros.
The Group's Canadian and Australian
businesses are also exposed
to a similar risk as the majority
of their purchases are denominated
in US dollars and Euros. The
Group's US businesses do not
have any material foreign currency
transactional risk.
-----------------------------------------------------------------
Accounting risk Relative movement to prior year
Inventory obsolescence No change
-----------------------------------------------------------------
Risk description and assessment Mitigation
Working capital management is Inventory write-offs are controlled
critical to success in specialised and minimised by active management
industrial distribution businesses and inventory levels based on
as this has a major impact on sales forecasts and regular
cash flow. The principal risk cycle counts.
to working capital is in inventory
obsolescence and write-off. Where necessary, a provision
is made to cover both excess
The charge against operating inventory and potential obsolescence.
profit in respect of old or
surplus inventory in the year
was GBP1.5m but inventories
are generally not subject to
technological obsolescence.
-----------------------------------------------------------------
RESPONSIBILITY STATEMENT OF THE DIRECTORS
IN RESPECT OF THE ANNUAL REPORT 2018
The Directors confirm that to the best of their knowledge:
-- the Group's consolidated financial statements, prepared in
accordance with IFRS as adopted by the EU and the Parent Company
financial statements, prepared in accordance with UK Accounting
Standards, give a true and fair view of the assets, liabilities,
financial position and profit of the Group and Parent Company and
the undertakings included in the consolidation taken as a
whole;
-- the Annual Report & Accounts includes a fair review of
the development and performance of the business and the position of
the Group and the undertakings included in the consolidation taken
as a whole, together with a description of the principal risks and
uncertainties faced by the Group; and
-- the Annual Report & Accounts, taken as a whole, are fair,
balanced and understandable and provide the information necessary
for shareholders to assess the Company's position and performance,
business model and strategy.
This responsibility statement was approved by the Board of
Directors on 19 November 2018 and is signed on its behalf by:
NP Lingwood JE Nicholas
Group Finance Director Executive Chairman
Registered office:
12 Charterhouse Square
London
EC1M 6AX
CONSOLIDATED INCOME STATEMENT
For the year ended 30 September 2018
2018 2017
Note GBPm GBPm
------------------------------ ----- -------- ---------
Revenue 3,4 485.1 451.9
Cost of sales (312.2) (290.8)
------------------------------ ----- -------- ---------
Gross profit 172.9 161.1
Distribution costs (10.8) (10.6)
Administration costs (88.9) (82.0)
------------------------------ ----- -------- ---------
Operating Profit 3 73.2 68.5
Financial expense, net 5 (0.5) (1.7)
------------------------------ ----- -------- ---------
Profit before tax 72.7 66.8
Tax expense 6 (18.3) (18.6)
------------------------------ ----- -------- ---------
Profit for the year 54.4 48.2
------------------------------ ----- -------- ---------
Attributable to:
Shareholders of the Company 53.8 47.5
Minority interests 0.6 0.7
------------------------------ ----- -------- ---------
54.4 48.2
------------------------------ ----- -------- ---------
Earnings per share
Basic and diluted earnings 7 47.5p 42.0p
------------------------------ ----- -------- ---------
Alternative Performance Measures (note
2) 2018 2017
Note GBPm GBPm
---------------------------------------- ---- ----- -------- --------
Operating profit 73.2 68.5
Add: Acquisition related charges 3 9.6 9.7
Add: CEO transition costs 15 2.1 -
Adjusted operating profit 3,4 84.9 78.2
Deduct: Interest expense 5 (0.1) (0.7)
---------------------------------------------- ----- -------- --------
Adjusted profit before tax 84.8 77.5
---------------------------------------------- ----- -------- --------
Adjusted earnings per share 7 56.4p 49.8p
---------------------------------------------- ----- -------- --------
CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
For the year ended 30 September 2018
2018 2017
GBPm GBPm
----------------------------------------------------------- ------ --------
Profit for the year 54.4 48.2
------------------------------------------------------------ ------ --------
Items that will not be reclassified to the Consolidated
Income Statement
Actuarial (losses)/gains in the defined benefit
pension schemes (1.0) 7.1
Deferred tax on items that will not be reclassified 0.2 (1.3)
------------------------------------------------------------ ------ --------
(0.8) 5.8
----------------------------------------------------------- ------ --------
Items that may be reclassified to Consolidated Income
Statement
Exchange rate gains/(losses) on foreign currency
net investments 0.1 (0.8)
Gains/(losses) on fair value of cash flow hedges 0.7 (1.0)
Net changes to fair value of cash flow hedges transferred
to the Consolidated Income Statement 0.9 (0.2)
Deferred tax on items that may be reclassified (0.4) 0.3
------------------------------------------------------------ ------ --------
1.3 (1.7)
----------------------------------------------------------- ------ --------
TOTAL COMPREHENSIVE INCOME FOR THE YEAR 54.9 52.3
------------------------------------------------------------ ------ --------
Attributable to:
Shareholders of the Company 54.2 51.6
Minority interests 0.7 0.7
------------------------------------------------------------ ------ --------
54.9 52.3
----------------------------------------------------------- ------ --------
CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
For the year ended 30 September 2018
Share-holders'
Share Translation Hedging Retained equity Minority Total
capital reserve reserve earnings interests equity
GBPm GBPm GBPm GBPm GBPm GBPm GBPm
-------------------- ---------- -------------- ---------- ----------- --------------- ------------ ---------
At 1 October 2016 5.7 30.5 0.2 197.1 233.5 4.3 237.8
Total Comprehensive
Income - (0.8) (0.9) 53.3 51.6 0.7 52.3
Share-based payments - - - 0.8 0.8 - 0.8
Tax on income
recognised
directly in equity - - - 0.3 0.3 - 0.3
Notional purchase of
own shares - - - (0.7) (0.7) - (0.7)
Dividends - - - (23.5) (23.5) (0.2) (23.7)
At 30 September 2017 5.7 29.7 (0.7) 227.3 262.0 4.8 266.8
Total Comprehensive
Income - 0.1 1.2 52.9 54.2 0.7 54.9
Share-based payments - - - 1.0 1.0 - 1.0
Minority interest
acquired - - - 2.5 2.5 (2.5) -
Minority interest
contribution - - - - - 0.3 0.3
Tax on items
recognised
directly in equity - - - 0.5 0.5 - 0.5
Notional purchase of
own shares - - - (2.2) (2.2) - (2.2)
Dividends - - - (26.8) (26.8) (0.2) (27.0)
--------------------- ---------- -------------- ---------- ----------- --------------- ------------ ---------
AT 30 SEPTEMBER 2018 5.7 29.8 0.5 255.2 291.2 3.1 294.3
--------------------- ---------- -------------- ---------- ----------- --------------- ------------ ---------
CONSOLIDATED STATEMENT OF FINANCIAL POSITION
As at 30 September 2018
2018 2017
Note GBPm GBPm
--------------------------------------- ----- -------- --------
Non-current assets
Goodwill 10 128.5 122.8
Acquisition intangible assets 53.6 54.0
Other intangible assets 1.8 0.7
Investment 11 0.7 0.7
Property, plant and equipment 23.0 22.6
Deferred tax assets 0.3 0.2
---------------------------------------- ----- -------- --------
207.9 201.0
--------------------------------------- ----- -------- --------
Current assets
Inventories 82.9 73.2
Trade and other receivables 77.6 68.9
Cash and cash equivalents 9 36.0 22.3
---------------------------------------- ----- -------- --------
196.5 164.4
--------------------------------------- ----- -------- --------
Current liabilities
Trade and other payables (80.5) (69.7)
Current tax liabilities 6 (4.8) (4.0)
Other liabilities 13 (5.6) (2.5)
(90.9) (76.2)
--------------------------------------- ----- -------- --------
Net current assets 105.6 88.2
---------------------------------------- ----- -------- --------
Total assets less current liabilities 313.5 289.2
Non-current liabilities
Retirement benefit obligations (10.5) (9.9)
Other liabilities 13 - (4.1)
Deferred tax liabilities (8.7) (8.4)
---------------------------------------- ----- -------- --------
Net assets 294.3 266.8
---------------------------------------- ----- -------- --------
Equity
Share capital 5.7 5.7
Translation reserve 29.8 29.7
Hedging reserve 0.5 (0.7)
Retained earnings 255.2 227.3
---------------------------------------- ----- -------- --------
Total shareholders' equity 291.2 262.0
Minority interests 3.1 4.8
---------------------------------------- ----- -------- --------
Total equity 294.3 266.8
---------------------------------------- ----- -------- --------
CONSOLIDATED CASH FLOW STATEMENT
For the year ended 30 September 2018
2018 2017
Note GBPm GBPm
-------------------------------------------------- ----- ------- -------
OPERATING PROFIT 73.2 68.5
Acquisition related charges 8 9.6 9.7
CEO transition costs, unpaid 8,15 1.3 -
Non-cash items 8 5.3 5.1
Increase in working capital 8 (5.1) (4.0)
-------------------------------------------------- ----- ------- -------
Cash flow from OPERATING activities 84.3 79.3
Interest paid, net - (0.4)
Tax paid (19.0) (19.3)
-------------------------------------------------- ----- ------- -------
Net cash from operating activities 65.3 59.6
-------------------------------------------------- ----- ------- -------
Cash flow from investing activities
Acquisition of businesses (including expenses,
net of cash acquired) 12 (18.1) (19.5)
Deferred consideration paid 13 (0.3) (0.6)
Proceeds from sale of business (net of expenses) 12 4.0 -
Purchase of property, plant and equipment (5.3) (3.1)
Purchase of other intangible assets (1.3) (0.2)
Proceeds from sale of property, plant and
equipment - 0.1
-------------------------------------------------- ----- ------- -------
Net cash used in investing activities (21.0) (23.3)
-------------------------------------------------- ----- ------- -------
Cash flow from financing activities
Acquisition of minority interests 13 (2.0) -
Dividends paid to shareholders 14 (26.8) (23.5)
Dividends paid to minority interests (0.2) (0.2)
Purchase of own shares by Employee Benefit (1.2) -
Trust
Notional purchase of own shares on exercise
of share options (1.0) (0.7)
Repayment of borrowings, net 9 - (10.0)
-------------------------------------------------- ----- ------- -------
Net cash used in financing activities (31.2) (34.4)
-------------------------------------------------- ----- ------- -------
Net increase in cash and cash equivalents 13.1 1.9
Cash and cash equivalents at beginning of
year 22.3 20.6
Effect of exchange rates on cash and cash
equivalents 0.6 (0.2)
-------------------------------------------------- ----- ------- -------
Cash and cash equivalents at end of year 9 36.0 22.3
-------------------------------------------------- ----- ------- -------
ALTERNATIVE PERFORMANCE MEASURES (NOTE 2) 2018 2017
GBPm GBPm
---------------------------------------------- --- ----- -----
Net increase in cash and cash equivalents 13.1 1.9
Add: Dividends paid to shareholders 14 26.8 23.5
Dividends paid to minority interests 0.2 0.2
Acquisition of businesses (including
expenses) 12 18.1 19.5
Acquisition of minority interests 13 2.0 -
Deferred consideration paid 13 0.3 0.6
Repayment of borrowings, net 9 - 10.0
--------------------------------------------- --- ----- -----
FREE CASH FLOW 60.5 55.7
---------------------------------------------- --- ----- -----
CASH FUNDS 9 36.0 22.3
---------------------------------------------- --- ----- -----
1. GENERAL INFORMATION
Diploma PLC is a public limited company registered and domiciled
in England and Wales and listed on the London Stock Exchange. The
address of the registered office is 12 Charterhouse Square, London,
EC1M 6AX. The consolidated financial statements comprise the
Company and its subsidiaries (together referred to as "the Group")
and were authorised by the Directors for publication on 19 November
2018.
These statements are presented in UK sterling, with all values
rounded to the nearest 100,000, except where otherwise
indicated.
The consolidated financial statements, which have been prepared
in accordance with International Financial Reporting Standards
("IFRS"), as adopted by the European Union and in accordance with
the Companies Act 2006, as applicable to companies reporting under
IFRS. The accounting policies have been consistently applied in
2018 and the comparative year.
There were no new Standards, amendments or interpretations to
existing Standards which have been published and endorsed by the EU
and which have a significant impact on the results, financial
position or presentation of the consolidated financial statements
for the year ended 30 September 2018.
The financial information set out in this Preliminary
Announcement, which has been extracted from the audited
consolidated financial statements, does not constitute the Group's
statutory financial statements for the years ended 30 September
2018 and 2017. Statutory financial statements for the year ended 30
September 2017 have been delivered to the Registrar of Companies
and are available on the website at www.diplomaplc.com. The
statutory financial statements for the year ended 30 September
2018, which were approved by the Directors on 19 November 2018,
will be sent to shareholders on 7 December 2018 and delivered to
the Registrar of Companies, following the Company's Annual General
Meeting.
The auditor has reported on the consolidated financial
statements for the years ended 30 September 2018 and 2017. The
reports were unqualified, did not draw attention to any matters by
way of emphasis and did not contain a statement under Section 498
(2) or (3) of the Companies Act 2006.
The Company's Annual General Meeting will be held at 12.00
midday on 16 January 2019 in Brewers Hall, Aldermanbury Square,
London, EC2V 7HR. The Notice of Meeting will be sent out in a
separate Circular to shareholders.
2. ALTERNATIVE PERFORMANCE MEASURES
The Group uses a number of alternative (non-Generally Accepted
Accounting Practice ("non-GAAP")) performance measures which are
not defined within IFRS. The Directors use these measures for
internal management reporting in order to assess the operational
performance of the Group on a comparable basis and as such, these
measures should be considered alongside the IFRS measures. The
following non-GAAP measures are referred to in this Preliminary
Announcement:
2.1 Adjusted operating profit
At the foot of the Consolidated Income Statement, "adjusted
operating profit" is defined as operating profit before
amortisation and impairment of acquisition intangible assets,
acquisition expenses, adjustments to deferred consideration
(collectively, "acquisition related charges"), the costs of a
material restructuring (including the incremental costs related
directly to the change of the Chief Executive Officer in 2018) or
rationalisation of operations and the profit or loss relating to
the sale of businesses or property. The Directors believe that
adjusted operating profit is an important measure of the
operational performance of the Group.
2.2 Adjusted profit before tax
At the foot of the Consolidated Income Statement, "adjusted
profit before tax" is separately disclosed, being defined as
adjusted operating profit, after finance expenses (but before fair
value remeasurements under IAS39 in respect of future purchases of
minority interests) and before tax. The Directors believe that
adjusted profit before tax is an important measure of the
operational performance of the Group.
2.3 Adjusted earnings per share
"Adjusted earnings per share" ("adjusted EPS") is calculated as
the total of adjusted profit before tax, less income tax costs, but
including the tax impact on the items included in the calculation
of adjusted profit, less profit attributable to minority interests,
divided by the weighted average number of ordinary shares in issue
during the year. The Directors believe that adjusted EPS provides
an important measure of the earning capacity of the Group.
2.4 Free cash flow
At the foot of the Consolidated Cash Flow Statement, "free cash
flow" is reported, being defined as net cash flow from operating
activities, after net capital expenditure on fixed assets and
including proceeds received from business disposals, but before
expenditure on business combinations/investments and dividends paid
to both minority shareholders and the Company's shareholders. The
Directors believe that
free cash flow gives an important measure of the cash flow of
the Group, available for future investment or distribution to
shareholders.
2.5 Trading capital employed and ROATCE
In the Sector analysis in note 3, "trading capital employed" is
reported, being defined as net assets less cash and cash
equivalents and after adding back: borrowings; retirement benefit
obligations; deferred tax; and acquisition liabilities in respect
of future purchases of minority interests and deferred
consideration. Adjusted trading capital employed is reported as
being trading capital employed plus goodwill and acquisition
related charges previously written off (net of deferred tax on
acquisition intangible assets). Return on adjusted trading capital
employed ("ROATCE") at the Group and Sector level is defined as the
adjusted operating profit, divided by adjusted trading capital
employed and adjusted for the full year effect of major
acquisitions and disposals. The Directors believe that ROATCE is an
important measure of the profitability of the Group.
3. Business Sector Analysis
The Chief Operating Decision Maker ("CODM") for the purposes of
IFRS8 is the Chief Executive Officer (or interim Executive
Chairman). The financial performance of the Sectors are reported to
the CODM on a monthly basis and this information is used to
allocate resources on an appropriate basis.
For management reporting purposes, the Group is organised into
three main reportable business Sectors: Life Sciences, Seals and
Controls. These Sectors form the basis of the primary reporting
format disclosures below. Sector revenue represents revenue from
external customers; there is no inter-Sector revenue. Sector
results, assets and liabilities include items directly attributable
to a Sector, as well as those that can be allocated on a reasonable
basis.
Sector assets exclude cash and cash equivalents, deferred tax
assets and corporate assets that cannot be allocated on a
reasonable basis to a business Sector. Sector liabilities exclude
borrowings, retirement benefit obligations, deferred tax
liabilities, acquisition liabilities and corporate liabilities that
cannot be allocated on a reasonable basis to a business Sector.
These items are shown collectively in the following analysis as
"unallocated assets" and "unallocated liabilities",
respectively.
Life Sciences Seals Controls Group
2018 2017 2018 2017 2018 2017 2018 2017
GBPm GBPm GBPm GBPm GBPm GBPm GBPm GBPm
------------------------------------------- --------- -------- ------- ------- ------- ------- ------- -------
Revenue * existing businesses 134.7 125.9 208.0 195.3 137.3 130.7 480.0 451.9
- acquisitions - - 5.1 5.1
Revenue 134.7 125.9 208.0 195.3 142.4 130.7 485.1 451.9
Adjusted
operating
profit - existing businesses 23.9 23.3 36.0 31.9 24.6 23.0 84.5 78.2
- acquisitions - - 0.4 0.4
Adjusted operating profit 23.9 23.3 36.0 31.9 25.0 23.0 84.9 78.2
Acquisition related charges (2.4) (3.2) (5.0) (5.5) (2.2) (1.0) (9.6) (9.7)
CEO transition costs (2.1) -
------------------------------------------- --------- -------- ------- ------- ------- ------- ------- -------
operating Profit 21.5 20.1 31.0 26.4 22.8 22.0 73.2 68.5
------------------------------------------- --------- -------- ------- ------- ------- ------- ------- -------
Acquisition related charges of GBP9.6m (2017: GBP9.7m) comprises
GBP9.3m (2017: GBP10.3m) of amortisation of acquisition intangible
assets, GBP0.5m of acquisition expenses (2017: GBP0.4m) and a
credit of GBP0.2m relating to adjustments to deferred consideration
(2017: GBP1.0m credit).
Life Sciences Seals Controls Group
2018 2017 2018 2017 2018 2017 2018 2017
GBPm GBPm GBPm GBPm GBPm GBPm GBPm GBPm
---------------------------------- ---------- --------- ------- ------- ------- ------- -------- -------
Operating assets 43.5 42.2 80.1 74.6 59.3 48.1 182.9 164.9
Investment - - 0.7 0.7 - - 0.7 0.7
Goodwill 59.0 59.5 40.3 39.9 29.2 23.4 128.5 122.8
Acquisition intangible
assets 12.9 15.4 21.8 27.0 18.9 11.6 53.6 54.0
---------------------------------- ---------- --------- ------- ------- ------- ------- -------- -------
115.4 117.1 142.9 142.2 107.4 83.1 365.7 342.4
Unallocated assets:
- Deferred tax assets 0.3 0.2
- Cash and cash equivalents 36.0 22.3
- Corporate assets 2.4 0.5
---------------------------------- ---------- --------- ------- ------- ------- ------- -------- -------
Total assets 115.4 117.1 142.9 142.2 107.4 83.1 404.4 365.4
---------------------------------- ---------- --------- ------- ------- ------- ------- -------- -------
Operating liabilities (21.6) (21.3) (32.2) (26.6) (25.5) (21.1) (79.3) (69.0)
Unallocated liabilities:
- Deferred tax liabilities (8.7) (8.4)
- Retirement benefit obligations (10.5) (9.9)
- Acquisition liabilities (5.6) (6.6)
- Corporate liabilities (6.0) (4.7)
Total liabilities (21.6) (21.3) (32.2) (26.6) (25.5) (21.1) (110.1) (98.6)
---------------------------------- ---------- --------- ------- ------- ------- ------- -------- -------
Net assets 93.8 95.8 110.7 115.6 81.9 62.0 294.3 266.8
---------------------------------- ---------- --------- ------- ------- ------- ------- -------- -------
Alternative Performance Life
Measures Sciences Seals Controls Group
(Note 2) 2018 2017 2018 2017 2018 2017 2018 2017
GBPm GBPm GBPm GBPm GBPm GBPm GBPm GBPm
---------------------------------------------------------- ------ -------- ------ ------ ------- ------- ------- -------
NET ASSETS 93.8 95.8 110.7 115.6 81.9 62.0 294.3 266.8
Add/(deduct):
* Deferred tax, net 8.4 8.2
* Retirement benefit obligations 10.5 9.9
* Acquisition liabilities 5.6 6.6
* Cash and cash equivalents (36.0) (22.3)
------- -------
REPORTED TRADING CAPITAL
EMPLOYED 282.8 269.2
* Historic goodwill and acquisition related charges,
net of deferred tax 31.4 28.8 33.0 28.1 10.2 9.4 74.6 66.3
---------------------------------------------------------- ------ -------- ------ ------ ------- ------- ------- -------
ADJUSTED TRADING CAPITAL
EMPLOYED 125.2 124.6 143.7 143.7 92.1 71.4 357.4 335.5
Pro-forma adjusted operating
profit(1) 23.9 24.6 36.3 32.8 27.4 23.0 87.6 80.4
---------------------------------------------------------- ------ -------- ------ ------ ------- ------- ------- -------
ROATCE 19.1% 19.7% 25.3% 22.8% 29.8% 32.2% 24.5% 24.0%
---------------------------------------------------------- ------ -------- ------ ------ ------- ------- ------- -------
(1) After annualisation of adjusted operating profit of acquisitions
and disposals.
OTHER SECTOR INFORMATION Life Sciences Seals Controls Group
2018 2017 2018 2017 2018 2017 2018 2017
GBPm GBPm GBPm GBPm GBPm GBPm GBPm GBPm
------------------------------- --------- -------- ------ ------ ------- ------ ------ ------
Capital expenditure 3.5 2.0 2.0 1.1 1.1 0.2 6.6 3.3
Depreciation and amortisation 2.4 2.2 1.8 1.9 0.6 0.6 4.8 4.7
------------------------------- --------- -------- ------ ------ ------- ------ ------ ------
4. GEOGRAPHIC SEGMENT ANALYSIS BY ORIGIN
Adjusted Trading
operating Non-current capital Capital
Revenue profit assets(1) employed expenditure
2018 2017 2018 2017 2018 2017 2018 2017 2018 2017
GBPm GBPm GBPm GBPm GBPm GBPm GBPm GBPm GBPm GBPm
---------------- ------- ------ ------- ------- --------- -------- ------ ------ -------- --------
United Kingdom 130.2 118.4 23.5 20.6 54.1 42.3 79.2 60.1 0.6 0.3
Rest of Europe 115.2 112.8 17.6 17.2 57.0 58.6 76.9 76.9 1.5 0.6
North America 202.3 188.3 39.5 36.3 70.5 70.9 97.1 99.9 4.0 1.9
Rest of World 37.4 32.4 4.3 4.1 25.3 28.3 29.6 32.3 0.5 0.5
---------------- ------- ------ ------- ------- --------- -------- ------ ------ -------- --------
485.1 451.9 84.9 78.2 206.9 200.1 282.8 269.2 6.6 3.3
---------------- ------- ------ ------- ------- --------- -------- ------ ------ -------- --------
(1) Non-current assets exclude the investment and deferred tax
assets.
5. FINANCIAL EXPENSE, NET
2018 2017
GBPm GBPm
---------------------------------------------------------- ------ ------
Interest (expense)/income and similar charges
* bank facility and commitment fees (0.1) (0.3)
0.1 -
* interest income on bank deposits
* interest expense on bank borrowings - (0.1)
* notional interest expense on the defined benefit
pension scheme (0.1) (0.3)
------------------------------------------------------------ ------ ------
Net interest expense and similar charges (0.1) (0.7)
------------------------------------------------------------ ------ ------
* fair value remeasurement of put options (note 13) (0.4) (1.0)
------------------------------------------------------------ ------ ------
FINANCIAL EXPENSE, NET (0.5) (1.7)
------------------------------------------------------------ ------ ------
The fair value remeasurement of GBP0.4m (2017: GBP1.0m)
comprises GBP0.2m (2017: GBP0.5m) which relates to an unwinding of
the discount on the liability for future purchases of minority
interests and a movement in the fair value of the put options of
GBP0.2m debit (2017: GBP0.5m debit).
6. TAX EXPENSE
2018 2017
GBPm GBPm
------------------------------------------------------ ------ ------
Current tax
The tax charge is based on the profit for the year
and comprises:
- UK corporation tax 3.9 3.7
- Overseas tax 16.1 17.2
------------------------------------------------------ ------ ------
20.0 20.9
Adjustments in respect of prior year:
* UK corporation tax - (0.5)
- Overseas tax (0.1) 0.2
------------------------------------------------------ ------ ------
Total current tax 19.9 20.6
------------------------------------------------------ ------ ------
Deferred tax
The net deferred tax credit based on the origination
and reversal of timing differences comprises:
- United Kingdom (0.4) (1.9)
- Overseas (1.2) (0.1)
Total deferred tax (1.6) (2.0)
------------------------------------------------------ ------ ------
TOTAL TAX ON PROFIT FOR THE YEAR 18.3 18.6
------------------------------------------------------ ------ ------
Factors affecting the tax charge for the year:
The difference between the total tax charge calculated by
applying the effective rate of UK corporation tax of 19.0% to the
profit before tax of GBP72.7m and the amount set out above is as
follows:
2018 2017
GBPm GBPm
----------------------------------------------------------- ----- -----
Profit before tax 72.7 66.8
----------------------------------------------------------- ----- -----
Tax on profit at UK effective corporation tax rate of
19.0% (2017: 19.5%) 13.8 13.0
Effects of:
- higher tax rates on overseas earnings 4.0 5.3
- adjustments to current tax charge in respect of previous
years (0.1) (0.3)
- other permanent differences 0.6 0.6
----------------------------------------------------------- ----- -----
TOTAL TAX ON PROFIT FOR THE YEAR 18.3 18.6
----------------------------------------------------------- ----- -----
The Group earns its profits in the UK and overseas. The UK
corporation tax rate was reduced from 20.0% to 19.0% on 1 April
2017. As the Group prepares its consolidated financial statements
for the year to 30 September, the effective tax rate for UK
corporation tax in respect of the year ended 30 September 2018 was
19.0% (2017: 19.5%) and this rate has been used for tax on profit
in the above reconciliation.
The reduction in the effective rate of taxation reflects the
impact from the reduction in the US Federal corporate income tax
rate to 21% from 35%, effective from 1 January 2018. There was no
material impact from the revaluation of US deferred tax balances at
the reduced tax rate. The Group's US businesses account for ca. 26%
of Group revenues and adjusted operating profit before tax.
The Group's net overseas tax rate is higher than that in the UK,
primarily because the profits earned in the US, Canada and
Australia are taxed at higher rates than the UK.
The UK deferred tax assets and liabilities at 30 September 2018
have been calculated based on the future UK corporation tax rate of
17.0%, as substantively enacted at 30 September 2018.
At 30 September 2018, the Group had outstanding tax liabilities
of GBP4.8m (2017: GBP4.0m) of which GBP2.1m related to UK tax
liabilities and GBP2.7m related to overseas tax liabilities. These
amounts are expected to be paid within the next financial year.
7. EARNINGS PER SHARE
Basic and diluted earnings per share
Basic and diluted earnings per ordinary 5p share are calculated
on the basis of the weighted average number of ordinary shares in
issue during the year of 113,140,435 (2017: 113,133,341) and the
profit for the year attributable to shareholders of GBP53.8m (2017:
GBP47.5m). There were no potentially dilutive shares.
Adjusted earnings per share
Adjusted earnings per share, which is defined in note 2, is
calculated as follows:
2018 2017 2018 2017
pence pence
per share per share GBPm GBPm
---------------------------------------------------- ---------- ---------- ------- -------
Profit before tax 72.7 66.8
Tax expense (18.3) (18.6)
Minority interests (0.6) (0.7)
---------------------------------------------------- ---------- ---------- ------- -------
Earnings for the year attributable to shareholders
of the Company 47.5 42.0 53.8 47.5
Acquisition related charges 8.4 8.6 9.6 9.7
Fair value remeasurement of put options 0.4 0.9 0.4 1.0
CEO transition costs 1.8 - 2.1 -
Tax effects on above adjustments (1.7) (1.7) (2.0) (1.9)
ADJUSTED EARNINGS 56.4 49.8 63.9 56.3
---------------------------------------------------- ---------- ---------- ------- -------
8. RECONCILIATION OF CASH FLOW FROM OPERATING ACTIVITIES
2018 2018 2017 2017
GBPm GBPm GBPm GBPm
------------------------------------------ ------ ------ ------ ------
Operating profit 73.2 68.5
Acquisition related charges (note 3) 9.6 9.7
CEO transition costs (note 15) 2.1 -
------------------------------------------ ------ ------ ------ ------
Adjusted operating profit 84.9 78.2
CEO transition costs paid (note 15) (0.8) -
------------------------------------------ ------ ------ ------ ------
84.1 78.2
Depreciation or amortisation of tangible
and other intangible assets 4.8 4.7
Share-based payments expense 1.0 0.8
Defined benefit scheme expense (0.5) (0.4)
------------------------------------------ ------ ------ ------ ------
Non-cash items 5.3 5.1
------------------------------------------ ------ ------ ------ ------
Operating cash flow before changes in
working capital 89.4 83.3
Increase in inventories (8.3) (5.1)
Increase in trade and other receivables (5.2) (6.6)
Increase in trade and other payables 8.4 7.7
------------------------------------------ ------ ------ ------ ------
Increase in working capital (5.1) (4.0)
------------------------------------------ ------ ------ ------ ------
CASH FLOW FROM OPERATING ACTIVITIES,
BEFORE ACQUISITION EXPENSES 84.3 79.3
------------------------------------------ ------ ------ ------ ------
9. CASH FUNDS
The movement in cash during the year is as follows:
2018 2017
GBPm GBPm
------------------------------------------- ------- -------
Net increase in cash and cash equivalents 13.1 1.9
Decrease in borrowings - 10.0
------------------------------------------- ------- -------
13.1 11.9
Effect of exchange rates 0.6 (0.2)
------------------------------------------- ------- -------
Movement in net cash 13.7 11.7
Net cash funds at beginning of year 22.3 10.6
------------------------------------------- ------- -------
CASH FUNDS AT OF YEAR 36.0 22.3
------------------------------------------- ------- -------
Comprising:
Cash and cash equivalents 36.0 22.3
Borrowings - -
------------------------------------------- ------- -------
CASH FUNDS AT 30 SEPTEMBER 36.0 22.3
------------------------------------------- ------- -------
The Group has a committed multi-currency revolving facility of
GBP30.0m which expires on 1 June 2020 with an accordion option to
increase the committed facility by a further GBP30.0m up to a
maximum of GBP60.0m and a further option to extend the term up to
five years. At 30 September 2018, the Group has utilised none of
this facility (2017: GBPNil). Interest on this facility is payable
between 70 and 115bps over LIBOR, depending on the ratio of net
debt to EBITDA.
10. GOODWILL
Life Sciences Seals Controls Total
GBPm GBPm GBPm GBPm
------------------------ -------------- ------ --------- ------
At 1 October 2016 52.8 39.1 23.3 115.2
Acquisitions 6.1 1.4 - 7.5
Exchange adjustments 0.6 (0.6) 0.1 0.1
------------------------- -------------- ------ --------- ------
At 30 September 2017 59.5 39.9 23.4 122.8
Acquisitions (note 12) - - 5.7 5.7
Exchange adjustments (0.5) 0.4 0.1 -
------------------------- -------------- ------ --------- ------
AT 30 SEPTEMBER 2018 59.0 40.3 29.2 128.5
------------------------- -------------- ------ --------- ------
The Group tests goodwill for impairment at least once a year.
For the purposes of impairment testing, goodwill is allocated to
each of the Group's three operating Sectors. This reflects the
lowest level within the Group at which goodwill is monitored by
management and reflects the Group's strategy of acquiring
businesses to drive synergies across a Sector, rather than within
an individual business. The impairment test requires a "value in
use" valuation to be prepared for each Sector using discounted cash
flow forecasts. The cash flow forecasts are based on a combination
of annual budgets prepared by each business and the Group's
strategic plan. Beyond five years, cash flow projections utilise a
perpetuity growth rate of 2%.
The key assumptions used to prepare the cash flow forecasts
relate to gross margins, revenue growth rates and the discount
rate. The gross margins are assumed to remain sustainable, which is
supported by historical experience; revenue growth rates generally
approximate to average rates for the markets in which the business
operates, unless there are particular factors relevant to a
business, such as start-ups. The annual growth rates used in the
cash flow forecasts for the next five years represent the budgeted
rates for 2018 and thereafter, average growth rates for each
Sector; these annual growth rates then reduce to 2% over the longer
term.
The cash flow forecasts are discounted to determine a current
valuation using a single market derived pre-tax discount rate of
ca. 11% (2017: 12%). This single rate is based on the
characteristics of lower risk, non-technically driven, distribution
businesses operating generally in well developed markets and
geographies and with robust capital structures. As these features
are consistent between each of the Group's Sectors the Board
considers that it is more appropriate to use a single discount rate
applied to each Sector's cash flow forecasts.
Based on the criteria set out above, no impairment in the value
of goodwill in any of the Sectors was identified.
The Directors have also carried out sensitivity analysis on the
key assumptions noted above to determine whether a "reasonably
possible adverse change" in any of these assumptions would result
in an impairment of goodwill. The analysis indicates that a
"reasonably possible adverse change" would not give rise to an
impairment charge to goodwill in any of the three Sectors.
11. INVESTMENT
2018 2017
GBPm GBPm
------------ ------ ------
Investment 0.7 0.7
------------ ------ ------
The Group holds a 10% interest in the share capital of Kunshan J
Royal Precision Products Inc. ("JRPP"), a supplier to J Royal. The
Group has no involvement in the day-to-day operations or management
of JRPP. At 30 September 2018, there was no material difference
between the book value of this investment and its fair value.
12. ACQUISITION AND DISPOSAL of BUSINESSES
On 16 October 2017 the Group acquired the trade and net assets
of Coast Fabrications Inc. ("Coast"), based in California, US, for
total cash consideration of GBP1.2m (US$1.5m), which included
GBP0.1m of acquisition expenses. The Company now trades as
Clarendon Specialty Fasteners Inc.
On 21 August 2018 the Group acquired 100% of Caplink Limited and
FSC Global Limited (collectively, "FS Cables") based in St. Albans,
England, for the initial consideration of GBP24.3m, which included
GBP7.3m of surplus cash and was before acquisition expenses of
GBP0.4m. Maximum deferred consideration of GBP1.0m is payable based
on the performance of FS Cables for the 12 months ended 31 October
2018.
Set out below is an analysis of the net book values and fair
values relating to these acquisitions:
FS Cables Coast Total
---------------- ---------------- ----------------
Book Fair Book Fair Book Fair
value value value value value value
GBPm GBPm GBPm GBPm GBPm GBPm
---------------------------------- --- ------- ------- ------- ------- ------- -------
Acquisition intangible assets - 8.6 - 0.5 - 9.1
Deferred tax - (1.6) - - - (1.6)
Property, plant and equipment 0.3 - - - 0.3 -
Inventories 3.8 3.3 0.5 0.5 4.3 3.8
Trade and other receivables 2.5 2.5 0.3 0.3 2.8 2.8
Trade and other payables (0.4) (0.8) (0.3) (0.3) (0.7) (1.1)
Net assets acquired 6.2 12.0 0.5 1.0 6.7 13.0
Goodwill - 5.5 - 0.2 - 5.7
6.2 17.5 0.5 1.2 6.7 18.7
-------------------------------------- ------- ------- ------- ------- ------- -------
Cash paid 24.3 1.1 25.4
Cash acquired (7.8) - (7.8)
Expenses of acquisition 0.4 0.1 0.5
---------------------------------------- ------- ------- ------- ------- ------- -------
NET CASH PAID, AFTER ACQUISITION
EXPENSES 16.9 1.2 18.1
Deferred consideration payable
(note 13) 1.0 0.1 1.1
Less: expenses of acquisition (0.4) (0.1) (0.5)
---------------------------------------- ------- ------- ------- ------- ------- -------
Total consideration 17.5 1.2 18.7
---------------------------------------- ------- ------- ------- ------- ------- -------
The fair values set out above are provisional and will be
finalised in the next financial year. Goodwill of GBP5.7m
recognised on these acquisitions represents the amount paid for
future sales growth from both new customers and new products,
operating cost synergies and employee know-how.
From the date of acquisition to 30 September 2018, the newly
acquired Coast business contributed GBP4.0m to revenue and GBP0.2m
to operating profit, the newly acquired FS Cables business
contributed GBP1.1m to revenue and GBP0.2m to operating profit. If
these businesses had been acquired at the beginning of the
financial year, they would in aggregate have contributed on a
pro-rata basis GBP17.6m to revenue and GBP2.8m to operating profit.
However these amounts should not be viewed as indicative of the
results of these businesses that would have occurred, if these
acquisitions had been completed at the beginning of the year.
One 30 June 2018, Hercules Fluid Power Group, based in the US,
sold the Bulldog Hydraulics and Gaskets business and trading assets
at net asset value for net cash consideration of GBP4.0m (US$5.4m),
comprising tangible assets of GBP0.3m and net working capital of
GBP3.7m. The business contributed revenues of GBP4.7m and an
operating loss of GBP0.3m for the nine months ended 30 June
2018.
13. OTHER LIABILITIES
2018 2017
GBPm GBPm
------------------------------------------------- -------- -------
Future purchases of minority interests 4.5 6.1
Deferred consideration 1.1 0.5
---------------------------------------------------- -------- -------
5.6 6.6
------------------------------------------------- -------- -------
Analysed as:
Due within one year 5.6 2.5
Due after one year - 4.1
---------------------------------------------------- -------- -------
The movement in the liability for future purchases of minority
interests is as follows:
2018 2017
GBPm GBPm
------------------------------------------------- -------- -------
At 1 October 6.1 5.1
Acquisition of minority interests (2.0) -
on exercise of options
Unwinding of discount 0.2 0.5
Fair value remeasurements 0.2 0.5
---------------------------------------------------- -------- -------
AT 30 SEPTEMBER 4.5 6.1
---------------------------------------------------- -------- -------
At 30 September 2018, the Group retained put options to acquire
minority interests in Kentek and M Seals.
On 17 November 2017 and 30 March 2018, the Group completed the
acquisition of the outstanding 10% minority interest in TPD for
cash consideration of GBP2.0m (EUR2.3m). At 30 September 2018, the
Group retained put options to acquire minority interests of 10%
held in each of M Seals and Kentek which are both exercisable from
November 2018.
At 30 September 2018, the estimate of the financial liability to
acquire the outstanding minority shareholdings was reassessed by
the Directors, based on their current estimate of the future
performance of these businesses and to reflect foreign exchange
rates at 30 September 2018. This led to a remeasurement of the fair
value of these put options and the liability was increased by
GBP0.2m (2017: GBP0.5m) reflecting a revised estimate of the future
performance of the businesses and by a further GBP0.2m (2017:
GBP0.5m) charge which arises from unwinding the discount on the
liability. In aggregate GBP0.4m (2017: GBP1.0m) has been charged to
the Consolidated Income Statement.
Deferred consideration comprises the following:
2018 2017
GBPm GBPm
----------------- ------ ------
Ascome - 0.1
Edco - 0.4
Coast 0.1 -
FS Cables 1.0 -
----------------- ------ ------
AT 30 SEPTEMBER 1.1 0.5
----------------- ------ ------
The amounts outstanding at 30 September 2018 are expected to be
paid within the next twelve months and will largely be based on the
performance of these businesses in the period following their
acquisition by the Group.
During the year, outstanding deferred consideration of GBP0.2m
was paid to the vendors of Edco in respect of the performance of
the business in the year ended 30 April 2018 and GBP0.1m was paid
to the vendor of Ascome. A further GBP0.2m has been released to the
Consolidated Income Statement as part of acquisition related
charges in note 3.
14. DIVIDS
2018 2017
pence pence 2018 2017
per share per share GBPm GBPm
----------------------------------- ----------- ----------- ------ ------
Interim dividend, paid in June 7.7 7.0 8.7 7.9
Final dividend of the prior year,
paid in January 16.0 13.8 18.1 15.6
----------------------------------- ----------- ----------- ------ ------
23.7 20.8 26.8 23.5
----------------------------------- ----------- ----------- ------ ------
The Directors have proposed a final dividend in respect of the
current year of 17.8p per share (2017: 16.0p) which will be paid on
23 January 2019, subject to approval of shareholders at the Annual
General Meeting on 16 January 2019. The total dividend for the
current year, subject to approval of the final dividend, will be
25.5p per share (2017: 23.0p).
15. CHIEF EXECUTIVE OFFICER TRANSITION COSTS
Richard Ingram joined the Board on 23 April 2018 and was
appointed Chief Executive Officer ("CEO") on 8 May 2018. Bruce
Thompson retired as both CEO and as Executive Director on 8 May
2018, but remained available to support an orderly transition until
his retirement from the Company on 30 September 2018. Accordingly
for a period of time during the year, the Company was bearing the
cost of two CEO roles.
On 28 August 2018, Richard Ingram stepped down from his role as
both CEO and Executive Director and left the Company with immediate
effect.
The one-off and incremental costs associated with the transition
of the CEO comprise a significant restructuring cost to the Group
and have been excluded in determining adjusted operating profit to
present the operational performance of the Group on a consistent
basis. The costs relating to the CEO transition of GBP2.1m
comprise:
Charged Outstanding
in year Paid in at 30 September
year
GBPm GBPm GBPm
------------------------------------------ --------- ---------- -----------------
Employment costs
* as CEO 0.3 (0.3) -
* in lieu of notice 0.5 (0.1) 0.4
Compensation on loss of office 0.4 - 0.4
Recruitment costs(1) 0.6 (0.3) 0.3
Other related costs, including advisors 0.3 (0.1) 0.2
------------------------------------------ --------- ---------- -----------------
2.1 (0.8) 1.3
------------------------------------------ --------- ---------- -----------------
(1) Includes recruitment costs relating to a new recruitment
search process that commenced in August 2018.
16. EXCHANGE RATES
The rates used to translate the results of the overseas
businesses are as follows:
Average Closing
2018 2017 2018 2017
------------------------ ----- ----- ----- -----
US dollar (US$) 1.35 1.27 1.30 1.34
Canadian dollar (C$) 1.73 1.67 1.69 1.68
Euro (EUR) 1.13 1.15 1.12 1.13
Swiss franc (CHF) 1.31 1.26 1.27 1.30
Australian dollar (A$) 1.78 1.67 1.80 1.71
------------------------ ----- ----- ----- -----
17. SUBSEQUENT EVENTS
On 12 October 2018, the Group completed the acquisition of
Actios SAS, the parent company of the Gremtek Group ("Gremtek") of
companies. Gremtek is a leading supplier of own-branded protective
sleeving and cable identification products to a broad range of
industrial markets, principally in France, but also in Germany and
elsewhere in Europe. The initial consideration was GBP7.4m
(EUR8.4m) with deferred consideration payable of up to GBP0.5m
(EUR0.6m), based on performance in the year ending 31 December
2018. A review to determine fair values of the net assets acquired
will be completed during the next financial year.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
FR LLFSRLTLRLIT
(END) Dow Jones Newswires
November 19, 2018 02:00 ET (07:00 GMT)
Diploma (LSE:DPLM)
Historical Stock Chart
From Apr 2024 to May 2024
Diploma (LSE:DPLM)
Historical Stock Chart
From May 2023 to May 2024